TABLE OF CONTENTS


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.  )
Filed by the Registrant  ý                            Filed by a Party other than the Registrant  ¨
Filed by the Registrant ☒
Filed by a Party other than the Registrant  ☐
Check the appropriate box:
ý

Preliminary proxy statement
¨

Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2))
¨
Definitive proxy statement
¨

Definitive additional materials
¨

Soliciting material pursuant to §240.14a-12
Travelzoo
(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
      Travelzoo
          (Name of Registrant as Specified in Its Charter)
           (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of filing fee (Check the appropriate box)all boxes that apply):
ý
No fee required
¨
 ☐
Fee paid previously with preliminary materials
 ☐
Fee computed on table belowin exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

TABLE OF CONTENTS

Title of each class of securities to which transaction applies:

Aggregate number of securities to which transaction applies:
Travelzoo
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11:
Proposed maximum aggregate value of transaction:
Total fee paid:



¨Fee paid previously with preliminary materials.
¨Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
Amount Previously Paid:
Form, Schedule or Registration Statement No.:
Filing Party:
Date Filed:













  travelzoologo11302017a17.jpg
Travelzoo
590 Madison Avenue, 35th Floor
New York, NY 10022

ISSUANCE PROPOSED – YOUR VOTE IS VERY IMPORTANTApril 28, 2023
Dear Stockholders:

You are cordially invited to attend a special meetingthe Annual Meeting of stockholders of Travelzoo, a Delaware corporation (the “Company”), to be held in virtual format only on December 28, 2022, at 10:00 a.m. (Eastern Time).

The Company entered into a stock purchase agreement with Azzurro Capital Inc., a company organized under the laws of the Cayman Islands and the Company’s largest shareholder (“Azzurro”), dated as of November 25, 2022 (the “Stock Purchase Agreement”), pursuant to which the Company will sell to Azzurro 3,410,000 newly issued shares of common stock of the Company (the “Issuance”) in exchange for consideration comprised of (a) $10 million, payable at the election of Azzurro, in cash or as a combination of no less than $2 million in cash and up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of Metaverse Travel Experiences, Inc., a New York corporation and wholly owned subsidiary of Azzurro (“MTE”).Following the consummation of the Issuance, Azzurro and its affiliates will own greater than 50% of the common stock of the Company.

At a special meeting of stockholders, you will be asked to consider and vote on a proposal to approve the Issuance. After careful consideration, and after having received independent legal and financial advice, a special committee of the board of directors of the Company, comprised solely of independent directors, has unanimously approved the Stock Purchase Agreement, the Issuance and the other transactions, including the acquisition of MTE via a merger transaction, contemplated by the Stock Purchase Agreement, and determined that the Issuance and related transactions are fair to and in the best interests of the Company and its stockholders. THE SPECIAL COMMITTEE OF THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE PROPOSAL TO APPROVE THE ISSUANCE.

The special meeting will be held on December 28, 2022 at 10:00 a.m. (Eastern Time) virtually via webcast at:

www.virtualshareholdermeeting.com/TZOO2022SM

Notice of the special meeting and the related proxy statement are enclosed. The attached proxy statement provides you with detailed information about the special meeting, the Issuance, the Stock Purchase Agreement and the acquisition of MTE. A copy of the Stock Purchase Agreement is attached as Annex A to the proxy statement. We encourage you to read the entire proxy statement and the Stock Purchase Agreement carefully. You may also obtain more information about the Company from the documents we have filed with the Securities and Exchange Commission.

Your vote is very important regardless of the number of shares you own. We cannot consummate the Issuance and therefore receive the cash (and, if applicable, promissory note) and consummate the acquisition of MTE unless the majority of shares present in person or by proxy and entitled to vote at the special meeting vote in favor of the proposal to approve the Issuance.

The consummation of the Issuance is also subject to the satisfaction of certain other conditions to closing as set forth in the Stock Purchase Agreement, which is attached to this proxy statement as Annex A.

Whether or not you plan to attend the special meeting, please complete, sign, date, and return the enclosed proxy card as soon as possible to ensure your representation at the special meeting. We have provided a postage-paid envelope for your convenience. If you plan to attend the special meeting and prefer to vote in person, you may still do so even if you have already returned your proxy card.

If you are a stockholder of record (that is, if your stock is registered with us in your own name), then you may vote by telephone or electronically via the Internet by following the instructions included in the proxy statement and with your proxy card. If your shares are registered in the name of a broker, bank or other nominee, your nominee may be participating in a program provided through Broadridge Financial Solutions, Inc. that allows you to vote by telephone or via the Internet. If so, the voting form that your nominee sends you will provide telephone and Internet instructions.






We look forward to seeing you at the special meeting. Thank you in advance for your cooperation and continued support.
Sincerely,
Michael Karg
Volodymyr Cherevko
Carrie Liqun Liu
Comprising the Special Committee
of the Board of Directors of Travelzoo

Neither the Securities and Exchange Commission nor any state securities regulatory agency has approved or disapproved the Issuance, passed upon the merits of the Issuance or the fairness of the Issuance or consideration received or passed upon the adequacy or accuracy of the disclosure in this document. Any representation to the contrary is a criminal offense.

The accompanying proxy statement is dated November 25, 2022 and, together with the enclosed form of proxy card, is first being mailed to stockholdersStockholders of Travelzoo on or about December 5, 2022.








TRAVELZOO
590 Madison Avenue
35th Floor
New York, NY 10022
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
To Be Held On December 28, 2022

To the Stockholders of Travelzoo:

NOTICE IS HEREBY GIVEN that a special meeting of stockholders ofJune 1, 2023 at 10 a.m. Eastern Time (ET). Travelzoo a Delaware corporation (“Travelzoo”, the “Company”, “we”, “us” or “our”), will be held on December 28, 2022 at 10:00 a.m. (Eastern Time),hold its 2023 Annual Meeting in a virtual meeting format only, via webcastwebcast. You can access the meeting at:
www.virtualshareholdermeeting.com/TZOO2023
If you encounter any difficulties while accessing the virtual meeting during the check-in or meeting time, a technical assistance phone number will be made available at www.virtualshareholdermeeting.com/TZOO2022SM, foron the following purposes:

To vote on a proposalvirtual meeting registration page 15 minutes prior to approve the issuance and sale of 3,410,000 shares of common stock of the Company, pursuant to the stock purchase agreement, dated November 25, 2022 (the “Stock Purchase Agreement”), between the Company and Azzurro Capital Inc. (“Azzurro”), in exchange for consideration comprised of (a) $10 million, payable at the election of Azzurro in cash or as a combination of no less than $2 million in cash and the remaining up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of Metaverse Travel Experiences, Inc., a New York corporation and wholly owned subsidiary of Azzurro (“MTE”), such that following the consummation of the proposed issuance, Azzurro and its affiliates will own greater than 50% of the common stock of the Company (the “Issuance Proposal”); and
To vote on a proposal to approve the adjournment or postponement of the special meeting to a later date or dates (1) if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the start time of the special meeting to approve the Issuance Proposal, or (2) if the failure to adjourn or postpone would reasonably be expected to be a violation of applicable law for the distribution of any required amendment or supplement to the proxy statement accompanying this notice to be timely provided to Travelzoo stockholders (the “Adjournment Proposal”).

The foregoing items of business are more fully described in the proxy statement.

The special committee (“Special Committee”) of the board of directors meeting.
In connection with the meeting, we enclose a notice of the Company (the “Board”) has fixed the close of business on November 22, 2022, as the record date (the “Record Date”) for the determination of stockholders entitled to notice of and to vote at the special meeting, and at any adjournment or postponement thereof. A list of stockholders entitled to vote at the special meeting will be available for inspection at our offices 10 days before the special meeting.

After careful consideration, the Special Committee unanimously recommends that you vote:

FOR the Issuance Proposal; and

FOR the Adjournment Proposal.

This a proxy statement is dated November 25, 2022 and a proxy card. This proxy statement or notice thereof is first being mailed or furnished to stockholders on or about December 5, 2022.
By Order of the Special Committee of the Board of Directors,
TRAVELZOO

All stockholders are cordially invitedApril 28, 2023. Detailed information relating to attend the special meeting virtually. Whether or not you expect to attend the special meeting, please complete, sign, dateTravelzoo’s activities and return the enclosed proxy cardoperating performance is contained in our 2022 Annual Report on Form 10-K, as soon as possible to ensure your representation at the special meeting. A postage-paid return envelope is enclosed for your convenience. Stockholders of record (that is, if your stock is registered with us in your own name and not in the name of a broker, bank or other nominee)may choose to vote those shares via the Internet at www.proxyvote.com or telephonically, within the United States and Canada, by calling toll free 1-800-690-6903 within the USA, US territories and Canada on a touch tone telephone. Even if you have given your proxy, you may still vote in person if you attend the special meeting. Please note, however, that if a broker, bank or other nominee holds your shares of record and you wish to vote at the special meeting, then you must obtain from the record holder a proxy issued in your name.

1



TABLE OF CONTENTS
Page
SUMMARY OF THE ISSUANCE AND THE MERGER
QUESTIONS AND ANSWERS ABOUT THE ISSUANCE AND THE SPECIAL MEETING
RISK FACTORS
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION
APPROVAL OF THE ISSUANCE PROPOSAL
APPROVAL OF THE ADJOURNMENT OR POSTPONEMENT OF THE SPECIAL MEETING
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
DOCUMENTS INCORPORATED BY REFERENCE
ADDITIONAL INFORMATION
OTHER BUSINESS
STOCKHOLDER PROPOSALS FOR THE ANNUAL MEETING
ANNEX A – STOCK PURCHASE AGREEMENT
ANNEX B – OPINION OF THE FINANCIAL ADVISOR TO THE SPECIAL COMMITTEE




2



TRAVELZOO
590 Madison Avenue
35th Floor
New York, NY 10022

PROXY STATEMENT FOR SPECIAL MEETING OF STOCKHOLDERS

General Information

The Special Committee of the Board of Directors of Travelzoo, a Delaware corporation, is providing these proxy materials to you in connectionpreviously filed with the solicitation of proxies for use at our special meeting of stockholders to be held virtually at 10:00 a.m. (Eastern Time) Securities and Exchange Commission on December 28, 2022, or at any adjournment or postponement thereof, for the purposes stated herein. This proxy statement summarizes the information that you will need to know to vote in an informed manner.

SUMMARY OF THE ISSUANCE AND THE MERGER

This summary term sheet, together with the “Questions and Answers About the Issuance and the Special Meeting of Stockholders,” highlights selected information from this proxy statement and may not contain all of the information thatMarch 31, 2023, which is important to you.also enclosed. We urgeencourage you to read carefully the entire proxy statement,Form 10-K.
To attend the annexes, and the other documents to which we refer or which we incorporate by reference in order to fully understand the acquisition and the related transactions. See section “Additional Information” below. Except as otherwise specifically noted in this proxy statement, “the Company,” “we,” “our,” “us” and similar words in this proxy statement refer to Travelzoo and its subsidiaries.

Parties to the Issuance and the Merger

The Company

Travelzoo is a Delaware corporation that publishes travel and entertainment offers to members across the globe via an Internet platform and email newsletters. Travelzoo’s main driver of revenue, growth and profitability is its membership base (currently more than 30 million) and so Travelzoo is, and since inception has been, always looking for opportunities to either increase the size of its membership base (such as asset purchases, mergers and acquisitions or licensing arrangements) or expand its product offerings (such as the hotel platform, vouchers, including fully refundable vouchers and building a paid subscription membership).

Azzurro Capital Inc.

Azzurro Capital Inc. is a company organized under the laws of the Cayman Islands and operates as an investment manager. Azzurro’s sole shareholder is The Ralph Bartel 2005 Trust, whose sole beneficiary is Ralph Bartel, a member of our board of directors. Azzurro’s sole director is First Rock Directors Limited, a Gibraltar private company limited by shares.

Metaverse Travel Experiences, Inc., formerly known as Azzurro Brands Inc. (“MTE”)

Metaverse Travel Experiences, Inc. was incorporated on July 14, 2004 in New York as Devi Kroell Inc. and was originally a retailer specializing in luxury handbags and exotic skins. On February 13, 2014, the name “Devi Kroell Inc.” was amended to “Azzurro Brands Inc.” On January 3, 2022, MTE legally changed its name to “Metaverse Travel Experiences, Inc.” and hired a team of professionals who began building worldwide relationships with creators and providers of high quality Metaverse experiences with the goal of brokering contacts between such creators/experience providers and businesses planning to market Metaverse experiences to consumers. MTE began generating net operating losses (“NOLs”) in 2005. These NOLs were generated primarily by operating expenses and currently MTE contains approximately $63 million in NOLs.

3


Review by the Special Committee

Because the transaction involves a related party, the board of directors (the “Board”) appointed via unanimous written consent a special committee, comprised solely of independent and disinterested directors (the “Special Committee”), to determine whether a potential transaction would be in the best interests of the Company and its stockholders, other than Azzurro and its affiliates, and to review, evaluate and negotiate the terms of any definitive agreements, as well as appoint independent legal, financial, and other advisors, in their discretion. The Special Committee appointed Ballard Spahr LLP as its independent legal advisor (“Ballard Spahr”) and Stout Risius Ross LLC as its independent financial advisor (“Stout”).

The Stock Purchase Agreement

On November 25, 2022, we entered into a stock purchase agreement (the “Stock Purchase Agreement”) with Azzurro, providing for the issuance of 3,410,000 shares (the “Shares”) of common stock of the Company (the “Common Stock”), in exchange for consideration comprised of (a) $10 million, payable, at the election of Azzurro, in cash or as a combination of no less than $2 million in cash and up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of MTE(collectively, the “Purchase Price”), such that following the consummation of the proposed issuance, MTE will be a wholly owned subsidiary of the Company.As a result of the Issuance, Azzurro and its affiliates will own greater than 50% of the common stock of the Company immediately following the consummation of the transactions contemplated by the Stock Purchase Agreement.

The Stock Purchase Agreement is included as Annex A to this proxy statement.

The Promissory Note

In the event Azzurro elects not to pay the full $10 million in cash at the closing of the Issuance (the “Closing”), the Company agreed to accept up to $8 million of the Purchase Price in the form of a secured promissory note (the “Promissory Note”). The Promissory Note shall be full recourse, secured by a pledge of 2 million Shares, representing the principal value of the Promissory Note, plus a safety margin. The Promissory Note shall contain an interest rate of 12% per annum. An amount equal to the principal amount of the Promissory Note plus interest accrued thereon until March 15, 2023 minus $3 million shall be due on or before March 15, 2023, and the remaining $3 million plus accrued interest for the time from March 15, 2023 until June 30, 2023 shall be due on or before June 30, 2023. The principal amounts and interest owing under the Promissory Note may be prepaid by Azzurro without penalty.

The form of Promissory Note is included as Exhibit B to the Stock Purchase Agreement.

The Merger Agreement

The form of merger agreement (the “Merger Agreement”) attached to the Stock Purchase Agreement as Exhibit A provides that upon the closing of the Issuance, MTE will merge with and into Merger Sub Inc., a Delaware corporation (“Merger Sub"), with MTE as the surviving entity, and then, immediately following the merger of Merger Sub into MTE, and as part of the overall transaction, MTE will merge with and into Merger Sub LLC, a Delaware limited liability company (“Merger Sub LLC”) that will be disregarded as an entity separate from the Company, with Merger Sub LLC as the surviving entity. The Issuance and the Merger are anticipated to treated as a qualified stock purchase followed by a liquidation, which will not result in an ownership change, and which will more likely than not allow the Company to fully utilize the NOLs contained in MTE with no limitations.

The form of Merger Agreement is included as Exhibit A to the Stock Purchase Agreement.

Standstill

The Stock Purchase Agreement provides that Azzurro may not, for the period of 12 months following the Closing Date and subject only to customary exceptions, sell, transfer or dispose any shares of the Company held by Azzurro if such sale, transfer or disposal would reduce the total number of shares of the Company held by Azzurro below 3,410,000 (with such minimum number of shares to be held by Azzurro not including any shares that are issued in the Issuance and pledged as collateral securing the Promissory Note).


4


Representations, Warranties, and Indemnification

The Stock Purchase Agreement contains customary indemnification provisions, including for breaches of representations and warranties made by MTE and Azzurro, including tax representations relating specifically to the NOLs. In the case of a Loss (as defined in the Stock Purchase Agreement), Azzurro would be required to indemnify the Company.

Conditions That Must Be Satisfied or Waived for the Issuance to Occur

As more fully described in this proxy statement and in the Stock Purchase Agreement, the consummation of the Issuance depends on a number of conditions being satisfied or waived. These conditions include, among others, that the SPA shall be duly adopted by the affirmative vote of a majority of shares present in person or represented by proxy at a stockholders meeting with proper quorum and entitled to vote on the matter, that Azzurro shall have sufficient ownership prior to the Closing so that upon the issuance of the Shares, Azzurro, together with its affiliates, shall have greater than 50% ownership (in order to allow full utilization of the NOLs of MTE), that no governmental authority shall have enacted any order which would make the transaction illegal, and that the representations, warranties and covenants of MTE, Azzurro and the Company shall be true and correct as of the Closing Date, and that the Investor, MTE and the Company shall have complied in all material respects with the SPA and any related agreements.

Termination of the Stock Purchase Agreement

The Stock Purchase Agreement may be terminated and the Issuance abandoned at any time prior to the consummation of the Issuance in certain cases, by either the Company or Azzurro. No termination fee is payable by either party upon termination for any reason. The Stock Purchase Agreement may be terminated, subject to certain conditions, by either party if the transactions are not consummated by March 31, 2023.

Opinion of Stout Risius Ross LLC

On November 25, 2022, Stout Risius Ross LLC ("Stout") delivered its opinion to the Special Committee that, as of November 25, 2022 and based upon the subject to the factors and assumptions set forth therein, the aggregate consideration consisting of (a) $10 million, payable, at the election of Azzurro, in cash or as a combination of no less than $2 million in cash and up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of MTE, to be paid for 3,410,000 shares of Common Stock was fair, from a financial point of view, to the Company.

Stout’s opinion was directed to the Special Committee and only addressed the fairness, from a financial point of view, of the consideration to be paid by the Company pursuant the Issuance.The Opinion does not address any other aspect or implication of the Issuance. The summary of Stout’s opinion in this proxy statement is qualified in its entirety by reference to the full text of the written opinion. The full text of the written opinion of Stout, dated November 23, 2022, which sets forth assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex B. Stout provided advisory services and its opinion for the information and assistance of the Special Committee in connection with its consideration of the transaction. The Stout opinion is not a recommendation as to how any holder of the Company’s Common Stock should vote with respect to the Issuance or any other matter.

Basis of the Stockholder Approval Requirement

The Common Stock is listed on the Nasdaq Global Select Market and it is subject to the Listing Rules of the Nasdaq Stock Market LLC (“Nasdaq”). We are required under Nasdaq Listing Rule 5635(a) and 5635(d) to seek stockholder approval for the Issuance, since (i) the Issuance is to a shareholder holding 36.26% of the outstanding Common Stock (i.e., a “Substantial Shareholder” as defined under the Nasdaq Listing Rules) and is in an amount in excess of 5% of the issued and outstanding Common Stock as of the Record Date, and (ii) the Issuance does not involve a public offering and will constitute more than 20% of the outstanding shares of Common Stock of the Company (a “20% Issuance”) at a price that is less than the Minimum Price (as such term is defined under the Nasdaq Listing Rules).

If the Issuance Proposal is approved, upon the closing of the Issuance, Travelzoo would issue 3,410,000 shares of Common Stock, which would constitute 21.6% of the Common Stock issued and outstanding immediately after the Issuance.

It is important that you understand that we are not required to, nor are we seeking, stockholder approval for the acquisition of MTE, or the related Merger and Merger Agreement. Rather, we are seeking stockholder approval of the Issuance for the purposes of complying with the Nasdaq Listing Rules relating to the issuance of shares of Common Stock to a Substantial Shareholder and to a 20% Issuance at a price that is less than the Minimum Price.
5




Completion of the Issuance and the Merger

It is currently anticipated that the Issuance and the Merger will close as soon as possible after all requisite approvals are obtained and all conditions have been satisfied, or where not prohibited by applicable law, waived.

Date, Time and Place of the SpecialAnnual Meeting of Stockholders

The special meeting will be held virtually at www.virtualshareholdermeeting.com/TZOO2022SM at 10:00 a.m.(Eastern Time) on December 28, 2022.

Record Date, Outstanding Shares and Quorum Requirement

You are entitled to vote at the special meeting if you owned shares of our common stock at the close of business on November 22, 2022, the record date for the determination of stockholders entitled to vote at the meeting. The presence at the meeting, in person or by proxy, of the holders of a majority of the shares of our common stock issued and outstanding as of the close of business on the record date for the determination of stockholders entitled to vote at the meeting will constitute a quorum. On the Record Date, there were 12,399,709 shares of our Common Stock issued and outstanding.

Vote Required

Each share of our Common Stock outstanding on the Record Date for the determination of stockholders entitled to vote at the meeting will be entitled to one vote, in person or by proxy, on each matter submitted for the vote of stockholders. The approval of the Issuance requires the affirmative vote of a majority of the shares present in person or by proxy and entitled to vote at the special meeting.

Voting of Proxies

Any stockholder entitled to vote at the special meeting whose shares are registered in his, her or its name may submit a proxy by telephone or via the Internet in accordance with the instructions provided on the enclosed proxy card, or by returning the enclosed proxy card by mail, or may attend the special meeting and vote in person by appearing at the special meeting. If your shares are held in “street name” by a broker, bank, or other nominee, you should advise your broker, bank, or other nominee how to vote your shares using the instructions provided by your broker, bank, or other nominee. If you do not provide your broker, bank, or other nominee with instructions, your shares will not be voted and will have no effect on the approval of the Issuance and any proposal to adjourn the special meeting in order to solicit additional proxies in the event that there are insufficient proxies received to approve the Issuance at the special meeting.

Abstentions and Broker Non-Votes

Abstentions and broker non-votes (i.e., shares of Common Stock held by a broker, bank, or other nominee that are represented at the special meeting, but that the broker, bank, or other nominee is not empowered to vote on a particular proposal) will be counted in determining whether a quorum is present at the special meeting. Brokers, banks, and other nominees typically do not have discretionary authority to vote on non-routine matters.

The proposal to approve the Issuance and the proposal to approve the adjournment of the special meeting, if necessary, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the Issuance, are not routine matters and therefore a broker may not be entitled to vote shares held in street name on these proposals absent instructions from the beneficial holder of such shares. Consequently, if your shares are held in street name and you do not submit any voting instructions to your bank, broker or other nominee, your shares will not be voted on these proposals and will be considered a “broker non-vote.” In order to minimize the number of broker non-votes, we encourage you to provide voting instructions to the organization that holds your shares by carefully following the instructions provided in the Notice of Special Meeting of Stockholders.


6


Revocability of Proxies

As a stockholder of record, once you have submitted your proxy by mail, telephone or via the Internet, you may revoke it at any time before it is voted at the special meeting. You may revoke your proxy in any one of three ways:

you may grant another proxy marked with a later date (which automatically revokes the earlier proxy) using any of the methods described above (and until the applicable deadline for each method);
you may notify our Corporate Secretary in writing that you wish to revoke your proxy before it is voted at the special meeting at the following address: Corporate Secretary, Travelzoo, 590 Madison Avenue, 35th Floor, New York, NY 10022; or
you may vote in person at the special meeting.

Please note that if you hold your shares in “street name” through a broker, bank or other nominee and you have instructed your broker, bank or other nominee to vote your shares, the above-described options for changing your vote do not apply, and instead, you must follow the instructions received from your broker, bank or other nominee to change your vote.

Recommendation of the Special Committee as to the Issuance

After careful consideration, the Special Committee unanimously recommends that you vote FOR the proposal to approve the Issuance and FOR any proposal to adjourn the special meeting in order to allow the Company to solicit additional proxies in the event that there are insufficient proxies received to approve the proposal at the special meeting.

Interests of the Company’s Executive Officers and Directors in the Issuance

When considering the recommendation of the Special Committee, you should be aware that Azzurro is the Company’s largest stockholder and is wholly owned by The Ralph Bartel 2005 Trust, whose sole beneficiary is Ralph Bartel, the Chairman of the Board of the Company. Mr. Ralph Bartel’s brother, Mr. Holger Bartel, is the Global Chief Executive Officer of the Company and is affiliated with MTE as a member of its board of directors.

The Special Committee have taken these additional interests into considerations and ensured that a fair process was followed to avoid any conflicts of interest. The members of the Special Committee are independent, dis-interested directors, with no affiliation to Mr. Ralph Bartel, Mr. Holger Bartel, Azzurro or MTE. The Special Committee appointed independent financial and legal advisors to advise on the proposed transaction and ensure its fairness to the Company and all of its stockholders, excluding Azzurro and its affiliates.

Appraisal Rights

Under Delaware law, our stockholders do not have any “dissenters’ rights” or rights to an appraisal of the value of their shares in connection with the Issuance or the Merger.

Additional Information

You can find more information about the Company in the periodic reports and other information we file with the SEC. The information is available at the SEC’s public reference facilities and at the website maintained by the SEC at www.sec.gov. For a more detailed description of the additional information available, see section “Additional Information” below.






7



QUESTIONS AND ANSWERS ABOUT THE ISSUANCE AND THE SPECIAL MEETING

The following questions and answers briefly address some commonly asked questions about the Issuance and the special meeting. They may not include all the information that is important to stockholders of Travelzoo. Stockholders should carefully read this entire proxy statement, including the annexes and the other documents referred to or incorporated by reference herein.

Why am I receiving these proxy materials?

Travelzoo is sending these materials to its stockholders to help them decide how to vote their shares of Travelzoo common stock, which is referred to as the Common Stock with respect to the Issuance.

The Issuance cannot be completed unless approved by Travelzoo stockholders. Travelzoo is holding a special meeting of its stockholders to vote on the proposals necessary to complete the Issuance. Information about the special meeting and the Issuance is contained in this proxy statement.

The Issuance and Related Transactions

What is the proposed transaction for which I am being asked to vote?

The Issuance is the private placement of 3,410,000 Shares, with Azzurro, the Company’s largest stockholder holding 36.26% of the Company’s outstanding Common Stock as of the Record Date, in exchange for consideration payable at the closing as set forth in the Stock Purchase Agreement, comprised of (a) $10 million, payable, at the election of Azzurro, in cash or as a combination of no less than $2 million in cash and up to $8 million in the form of a secured promissory note, subject to certain adjustments at closing, discussed in further detail in the section entitled “Description of the Stock Purchase Agreement”, subsection “Purchase Price Adjustment”, and (b) all of the outstanding shares of MTE via a Merger outlined in further detail below and in the section entitled “The Merger Agreement”.

Why is the Company proposing the Issuance Proposal?

The Company is proposing the Issuance Proposal in order to comply with Nasdaq Listing Rule 5635(a) and 5635(d). Nasdaq Listing Rule 5635(a) requires stockholder approval prior to the issuance of securities in connection with the acquisition of the stock or assets of another company if any Substantial Shareholder (as defined by Rule 5635(e)(3)) in the consideration to be paid in the transaction and the potential issuance of common stock could result in an increase in the outstanding common shares of 5% or more. The Shares being issued, even solely in exchange for MTE and not considering the Shares issued in exchange for cash or the Promissory Note, constitute greater than 5% of the outstanding Common Stock.

In addition, Nasdaq Listing Rule 5653(d) requires stockholder approval prior to a 20% Issuance (meaning, a transaction other than a public offering, involving the issuance of common stock by a company, which equals 20% or more of the common stock outstanding before the issuance) at a price that is less than the Nasdaq Minimum Price (meaning the lower of the Nasdaq closing price immediately preceding the signing of the SPA or the average closing price for the five-day trading average). The Shares being issued constitute 27.5% of the Common Stock before the Issuance and the price of $5.88, which is based on the 15-day volume-weighted average price of the shares of common stock of the Company prior to the signing of the SPA, is less than the Minimum Price of $6.10.

What is the Merger?

The Merger refers to the acquisition of MTE by the Company, whereby at the closing of the Issuance pursuant to the Stock Purchase Agreement (the “Closing”) as set forth in the Merger Agreement, which is an exhibit to the Stock Purchase Agreement, MTE would merge with and into Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of the Company, which would then merge with and into Merger Sub LLC, a Delaware limited liability company and wholly owned subsidiary of the Company, with the surviving company as Metaverse Travel Experiences, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company.


8


When does Travelzoo and Azzurro expect to complete the Issuance and the Merger?

The Issuance would take place immediately following the receipt of approval of the Issuance Proposal by Travelzoo stockholders. The Merger would take place concurrently with the Closing. Accordingly, subject to receipt of stockholder approval at the special meeting, the Company anticipates closing the Issuance prior to December 31, 2022.

What conditions must be satisfied to complete the Issuance and the Merger?

There are a number of closing conditions in the Stock Purchase Agreement, including that the Company’s stockholders have approved the Issuance Proposal. For a summary of the conditions that must be satisfied or waived prior to the completion of the Issuance and the Merger, see the section entitled “Conditions That Must Be Satisfied or Waived for the Issuance to Occur”.

As a stockholder, what will I receive in the Issuance or the Merger?

Current stockholders of the Company will not receive anything in the Issuance or the Merger. As a result of the Issuance, our stockholders’ existing share ownership will be diluted by the issuance of the Shares, which will represent approximately 21.6% of our shares of Common Stock outstanding immediately after the consummation of the Issuance.

Is the Issuance expected to be taxable to me?

We do not believe the consummation of the Issuance or the Merger will have any material tax consequences on the holders of our existing shares of Common Stock, other than Azzurro and its affiliates.

What effects will the proposed Issuance have on the Company?

If the Issuance and the Merger are consummated, Azzurro and its affiliates will own greater than 50% of the Common Stock and MTE will become a wholly owned subsidiary of the Company. The Metaverse scouting business currently operated by MTE will be brought in-house to the Company and will result in a savings of at least $25,000 per month, plus additional commissions not yet charged, for the Travelzoo META business, upon the termination of the outstanding service agreement between MTE and the Company (the “Service Agreement”). Additionally, based on the analysis of Grant Thornton, tax advisor to the Company (“Grant Thornton”), it is more likely than not that the Company will be able to fully utilize the outstanding net operating losses (“NOLs”) of MTE on its tax returns in the United States. These NOLs are estimated at approximately $63 million, allowing significant tax savings for the next up to 10 years, and an immediate benefit of approximately $1.8 million for the tax year ended December 31, 2022.

What happens if the Issuance is not consummated?

If the Issuance is not approved by our stockholders, or if the Issuance is not consummated for any other reason, we will not issue the Shares, meaning the Company will not receive the consideration payable by Azzurro, including the cash, Promissory Note and MTE (which could assist the Company with additional liquidity during a time when its cash levels are forecasted to be lower), and MTE will not become a wholly owned subsidiary of the Company. Instead, MTE will continue independently owned by Azzurro and the Company will not be able to utilize the NOLs. Additionally, the Company will continue to work with MTE under the outstanding Service Agreement over the next four years, which will require payments of $25,000 per month (paid quarterly) and eventually significant commission payments upon the official launch of the Travelzoo META subscription business.

Am I entitled to appraisal or similar rights under Delaware law as a result of the Issuance or the Merger?

No. Under Delaware law, our stockholders do not have any “dissenters’ rights” or rights to an appraisal of the value of their shares in connection with the Issuance or the Merger.

The Special Meeting

Where and when is the special meeting?

The special meeting of the stockholders will take place on December 28, 2022 in a virtual meeting format only, available at www.virtualshareholdermeeting.com/TZOO2022SM. The meeting will begin at 10:00 am (Eastern Time).


9


To attend the special meeting and vote, you must be a stockholder of record as of November 22, 2022.5:00 p.m. ET on April 14, 2023. You will be able to attend the special meetingAnnual Meeting as well as vote during the meeting by visiting the link provided above and entering the 16-digit number included in your proxy card.
If you hold your shares in street name through a bank, broker, or other nominee, please have the control number set forth on your proxy card available for admittance to the meeting. You must check in via the meeting link in order to be admitted to the Annual Meeting of Stockholders.
Your vote is important. Whether or not you plan to attend the Annual Meeting of Stockholders, please vote your shares via mail with the enclosed proxy card. Please note that you can attend the virtual meeting and vote, even if you have previously voted by proxy.
Travelzoo will make available an alphabetical list of stockholders entitled to vote at the meeting for examination by any stockholder during ordinary business hours at Travelzoo’s office, located at 590 Madison Avenue, 35th Floor, New York, NY 10022, U.S.A., for ten days prior to the meeting. A stockholder may examine the list for any legally valid purpose related to the meeting.
On behalf of the entire Board of Directors of Travelzoo, we look forward to seeing you at the meeting.
Sincerely,
CHRISTINA SINDONI CIOCCA
Chair of the Board of Directors

TABLE OF CONTENTS

TRAVELZOO
590 Madison Avenue
35th Floor
New York, NY 10022
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held On June 1, 2023
To the Stockholders of Travelzoo:
NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of Travelzoo, a Delaware corporation (“Travelzoo” or the “Company”), will be held on June 1, 2023 at 10 a.m. ET, in a virtual meeting format only, via webcast available at www.virtualshareholdermeeting.com/TZOO2022SMTZOO2023, for the following purposes:
To elect five members of the Company's Board of Directors (the “Board”), each to serve until the 2024 Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal (“Proposal 1”);
To vote to approve an option grant to the General Counsel and Head of Global Functions (“Proposal 2”);
To vote, on an advisory basis, on the frequency of say-on-pay votes (“Proposal 3”);
To vote, on an advisory basis, to approve executive compensation (“Proposal 4”); and
To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
Only stockholders of record as of 5:00 p.m. ET on April 14, 2023 may vote at the Annual Meeting of Stockholders. Your vote is important. Whether you plan to attend the Annual Meeting or not, please cast your vote by completing, dating and signing the enclosed proxy card and returning it via the methods indicated on the proxy card. If you attend the virtual meeting and prefer to vote at that time, you may do so even if you have previously voted by proxy. Please retain the control number set forth on your proxy card so that we can verify your identity to admit you to the virtual meeting.
By Order of the Board of Directors,
TRAVELZOO
CHRISTINA SINDONI CIOCCA
Chair of the Board of Directors
1


TABLE OF CONTENTS

PROXY STATEMENT
FOR TRAVELZOO
2023 ANNUAL MEETING OF STOCKHOLDERS
INFORMATION ABOUT THE ANNUAL MEETING
Why am I receiving these proxy materials?
Travelzoo’s Board is soliciting proxies to be voted at the 2023 Annual Meeting of Stockholders. This proxy statement includes information about the matters to be voted upon at the meeting.
Only stockholders of record of our common stock, par value $0.01 per share (the “Common Stock”), as of 5:00 p.m. ET on April 14, 2023 (the “Record Date”) will be entitled to notice of, and to vote at, the Annual Meeting. As of the Record Date, there were 15,556,427 shares of our Common Stock issued and outstanding.
Where and when is the Annual Meeting?
The Annual Meeting of Stockholders will take place on June 1, 2023 in a virtual meeting format only at www.virtualshareholdermeeting.com/TZOO2023. The meeting will begin at 10:00 a.m. ET.
To attend the Annual Meeting and vote, you must be a stockholder of record as of 5:00 p.m. ET on April 14, 2023. You will be able to attend the Annual Meeting as well as vote during the meeting by visiting www.virtualshareholdermeeting.com/TZOO2023 and entering the 16-digit number included in your proxy card. If you encounter any difficulties while accessing the virtual meeting please callduring the check-in or meeting time, a technical support number: 1-844-986-0822 (toll free) or 1-303-562-9302 (international).

assistance phone number will be made available on the virtual meeting registration page 15 minutes prior to the start time of the meeting.
What am I voting on?

Stockholders are being asked towill vote on the followingfour proposals:

To vote on a proposal to approve the issuance of 3,410,000 shares of common stock of the Company, pursuant to the stock purchase agreement, dated November 25, 2022 (the “Stock Purchase Agreement”), between the Company and Azzurro Capital Inc. (“Azzurro”), in exchange for consideration comprised of (a) $10 million, payable at the election of Azzurro, in cash or as a combination of no less than $2 million in cash and the remaining up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of Metaverse Travel Experiences, Inc., a New York corporation and wholly owned subsidiary of Azzurro (“MTE”), such that following the consummation of the proposed issuance, Azzurro and its affiliates will own greater than 50% of the common stock of the Company (the “Issuance Proposal”); and
To vote on a proposal to approve adjournment or postponement of the special meeting to a later date or dates, if necessary or appropriate, (1) to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the Issuance Proposal, or (2) if the failure to adjourn or postpone would reasonably be expected to be a violation of applicable law for the distribution of any required amendment or supplement to the proxy statement accompanying this notice to be timely provided to Travelzoo stockholders (the “Adjournment Proposal”).

ApprovalA proposal to elect five members of the Issuance Company's Board, each to serve until the 2024 Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal (“Proposal by Travelzoo stockholders is required for completion1”);
A proposal to approve an option grant to the General Counsel and Head of Global Functions (“Proposal 2”);
A proposal to approve on an advisory basis the frequency of say-on-pay votes (“Proposal 3”); and
A proposal to approve on an advisory basis executive compensation (“Proposal 4”).
Stockholders will further transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Issuance.

Annual Meeting.
How does the Special CommitteeBoard recommend that you vote on the proposals?

The Special CommitteeBoard recommends that you vote your shares "FOR" the Issuance“FOR” Proposal 1, Proposal 2, Proposal 3 and “FOR” the Adjournment Proposal.Proposal 4.

Why is a Special Committee of the Board making the vote recommendation?

Because Azzurro, as the Company’s largest stockholder holding 36.26%, is a related party to the Company, the Board delegated its authority via a unanimous written consent for purposes of reviewing, negotiating, approving, authorizing, etc. the Issuance and the Merger to a Special Committee of the Board, comprised solely of independent directors. The Special Committee retained independent legal and financial advisors to assist in its review, negotiation, approval, authorization, etc. of the terms of the Issuance and the Merger and to ensure that the price of the Shares being issued by the Company and the consideration payable by Azzurro in connection with the Issuance, including the valuation of MTE, were fair and reasonable to the Company.

What factors did the Special Committee consider and what were its reasons for recommending that the stockholders approve the Issuance Proposal?

After careful consideration, the Special Committee determined that the Issuance Proposal is advisable and in the best interests of our stockholders and recommended that our stockholders vote in favor of the Issuance Proposal. For information regarding the factors the Board considered in making this determination, please refer to the disclosures set forth under the caption “Approval of the Issuance Proposal— Recommendation of the Special Committee.

How many votes do I have?

Per Travelzoo’s Amended and Restated By-laws, each stockholder is entitled to one (1) vote for each share of stockCommon Stock held which has voting power upon the matter in question. You may hold shares as follows:

Shares held directly in your name as the “stockholder of record” and
Shares held directly in your name as the “stockholder of record” and
Shares held for you as the beneficial owner through a broker, bank, or other nominee in “street name.”


10


If I am a stockholder of record, how can I vote my shares?

Stockholders can vote by proxy (via the Internet or by mail) or in person (at the virtual meeting), however, granting. Granting a proxy does not in any way affect your right to attend the special meetingAnnual Meeting and vote.
3

TABLE OF CONTENTS

How do I vote by proxy?

If you are a stockholder of record, you may vote your proxy by mail or by Internet. To vote by Internet, go to www.proxyvote.com,, enter your 16-digit number included on your proxy card and follow the instructions. You can vote by mail by mailing in your proxy card to: Vote Processing c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717, U.S.A.

Note, if you wish to receive a paper or e-mail copy of the materials, you must request one. There is no charge for requesting a copy. Please choose one of the following methods to make your request: (1) by Internet: www.proxyvote.com;www.proxyvote.com; (2) by telephone: 1-800-690-6903;1-800-579-1639; or (3) by e-mail: sendmaterial@proxyvote.com.sendmaterial@proxyvote.com. If requestingrequesting materials by e-mail, please send a blank e-mail with your 16-digit number included on your proxy card.

If you vote by proxy, the persons named on the card (your "proxies"“proxies”) will vote your shares in the manner you indicate.You may specify whether your shares should be voted for all, some or none of the nominees for director or any other proposals properly brought before the special meeting.Annual Meeting. If you sign your proxy card and do not indicate specific choices, your shares will be voted "FOR"“FOR” the issuance proposalelection of all nominees for director and “FOR” the adjournment proposal.Proposal 2, Proposal 3 and Proposal 4. If any other matter is properly brought before the meeting, your proxies will vote in accordance with the Company’s discretion. At the time of submitting this proxy statement for printing, we know of no matter that will be acted on at the special meetingAnnual Meeting of Stockholders other than those discussed in this proxy statement.

If you wish to give a proxy to someone other than the persons named on the enclosed proxy card, you may strike out the names appearing on the card and write in the name of any other person, sign the proxy, and deliver it to the person whose name has been substituted.

May I revoke my proxy?

If you give a proxy, you may revoke it in any one of three ways:

Submit a valid, later-dated proxy before the Annual Meeting,
Submit a valid, later-dated proxy before the special meeting,
Notify our Corporate Secretary in writing at Travelzoo, Attention: Corporate Secretary, 590 Madison Avenue, 35th Floor, New York, NY 10022, before the Special meetingAnnual Meeting that you have revoked your proxy, or
Vote virtually at the special meeting.

Vote virtually at the Annual Meeting.
How do I vote in person?

If you are a stockholder of record, you may cast your vote at the virtual special meetingAnnual Meeting by logging into the webcast available at www.virtualshareholdermeeting.com/TZOO2022SM.

TZOO2023.
If I hold shares in street name, how can I vote my shares?

You can submit voting instructions to your broker or nominee. In most instances, you will be able to do this over the Internet or by mail. Please refer to the voting instruction card included in the materials provided by your broker or nominee. If you wish to vote at the virtual special meeting,Annual Meeting, please have identification and proof of ownershipthe control number set forth on your proxy card available such as an account statement or letter from your bank or broker, for admittance to the virtual meeting.

What vote is required to approve each proposal at the special meeting?proposal?

Each share of our common stockCommon Stock is entitled to one (1) vote with respect to each matter on which it is entitled to vote. Pursuant to our Amended and Restated By-laws, our directors are elected by a majority of the votes cast at a meeting of the stockholders by the holders of stock entitled to vote in the election; provided, however, if the Corporate Secretary determines that the number of nominees for director exceeds the number of directors to be elected, directors will be elected by a plurality of the votes of the shares represented in person or by proxy at the meeting. For purposes hereof, a majority of votes cast means that the number of shares voted “for” a nominee must exceed the votes cast “against” such nominee. The following will not be votes cast: (a) a share whose ballot is marked as withheld; (b) a share otherwise present at the meeting but for which there is an abstention; and (c) a share otherwise present at the meeting for which a shareholder gives no authority or
4

TABLE OF CONTENTS

direction. The affirmative vote of a majority of the shares of the Company's Common Stock present in person or represented by proxy and entitled to vote on the proposal will be considered as the approval of Proposal 2 and, by an advisory vote, the issuance proposal andapproval of Proposal 4. Proposal 3 will be based on a plurality of the adjournment proposal.

votes of the shares represented in person or by proxy at the meeting.
In order to have a valid stockholder vote, a stockholder quorum must exist at the special meeting.Annual Meeting. A quorum will exist when stockholders holding a majority of the outstanding shares of Common Stock are present at the meeting, either in person or by proxy.
11


Azzurro Capital Inc., whose beneficial owner is Mr. Ralph Bartel, the founder of Travelzoo, holds an aggregate of 7,663,858 shares of our Common Stock, representing approximately 49% of the outstanding shares, as of April 14, 2023.
All properly executed proxies delivered pursuant to this solicitation and not revoked will be voted at the special meetingAnnual Meeting as specified in such proxies. As noted above, if no voting instructions are indicated, proxies will be voted as recommended by our Board on all matters, and in the discretion of the proxy holder on any other matters that properly come before the special meeting.

Annual Meeting.
What is a broker non-vote and how are broker non-votes and abstentions counted?

A broker "non-vote"“non-vote” occurs when a nominee holding shares of common stockCommon Stock for the beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item and has not received instructions from the beneficial owner. Brokers that have not received voting instructions from their clients cannot vote on their clients' behalf on "non-routine"“non-routine” proposals. The vote on the Issuance proposalProposals 1, 2, 3 and the Adjournment proposal4 are considered "non-routine"“non-routine”. Broker non-votes will be counted for the purpose of obtaining a quorum for the Annual Meeting but will not have any other effect with respect to the Issuance proposalProposals 1, 2, 3 and the Adjournment proposal,4, as shares that constitute broker non-votes are not considered entitled to vote but will be counted for the purposes of obtaining a quorum for the special meeting.

on these non-routine proposals.
Abstentions are counted as "shares present"“shares present” at the special meetingAnnual Meeting for purposes of determining the presence of a quorum and with respect to any matters being voted upon at the special meeting.Annual Meeting. As stated above (at “What vote is required to approve each proposal?”), abstentions will have no effect on the outcome of the election of directors, but with respect to any other proposal an abstention will have the same effect as a vote against anysuch proposal.

What happens if additional matters are presented at the special meeting?

Other than the item of business described in the proxy statement, we are not aware of any other business to be acted upon at the special meeting. If you grant a proxy, the persons named as proxy holders will have the discretion to vote your shares on any additional matters properly presented for a vote at the special meeting.

Where can I find the voting results of the special meeting?

We intend to announce preliminary voting results at the special meeting andAnnual Meeting. We will publish the final voting results in a Current Reportreport on Form 8-K, which we intend to be filed withfile within four (4) business days following the Annual Meeting. You can obtain a copy of the Form 8-K on Travelzoo's investor relations website at www.travelzoo.com/ir, by calling the U.S. Securities and Exchange Commission (“SEC”) withinat (800) SEC-0330 for the location of the nearest public reference room, or through the EDGAR system at www.sec.gov. Information on our website does not constitute part of this proxy statement.
5

TABLE OF CONTENTS

PROPOSAL 1—ELECTION OF DIRECTORS
Under Travelzoo's Amended and Restated By-laws, the number of directors of Travelzoo is fixed at five (5), and may be increased or decreased from time to time, by resolution of the Board. Note, Mr. Ralph Bartel resigned as a director in December 2022 and at that time the Board resolved to keep the Board at four business days after(4) until the special meeting.next election, when the number of directors would then return to five (5). Each director holds office for a term of one (1) year, until the Annual Meeting of Stockholders next succeeding the director's election and until a successor is elected and qualified or until the earlier resignation or removal of the director. The following individuals have been nominated for election to our Board, each to serve until the 2024 Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal.
Following is information about each nominee, including biographical data for at least the last five (5) years. Should one or more of these nominees become unavailable to accept nomination or election as a director, the individuals named as proxies on the enclosed proxy card will vote the shares that they represent for the election of such other persons as the Board may recommend, unless the Board reduces the number of directors. We have no reason to believe that any nominee will be unable or unwilling to serve if elected as a director.
Nominees for a One-Year Term That Will Expire in 2024:
The ages, principal occupations, directorships held and other information as of April 14, 2023, with respect to our nominees are described below.
Name
Age
Position
Holger Bartel, Ph.D.
56
Global Chief Executive Officer
Christina Sindoni Ciocca
35
Chair of the Board, Corporate Secretary, General Counsel and Head of Global Functions
Carrie Liqun Liu
41
Independent Director
Volodymyr Cherevko
38
Independent Director
Michael Karg, Ph.D.
51
Independent Director
Each of the director nominees listed above, other than Mr. Holger Bartel, is currently a director of Travelzoo and was previously elected by the shareholders. Mr. Michael Karg, Mr. Volodymyr Cherevko, Ms. Carrie Liqun Liu and Ms. Christina Sindoni Ciocca were elected directors of Travelzoo at the Company's Annual Meeting of Stockholders held on April 25, 2022. The independent directors will be appointed to the various committees (Compensation, Audit and Nominating and Corporate Governance) by the Board following their election at the Annual Meeting.
Our Board has determined that each of Ms. Liu, Mr. Cherevko and Mr. Karg meet the independence requirements of the listing standards of the NASDAQ Stock Market (“NASDAQ”). Mr. Karg’s current employer, Mindshare, is part of the WPP Group. Certain affiliates and subsidiaries of the WPP Group, including Mindshare, have from time-to-time represented clients of Travelzoo and purchased media on behalf of such clients from Travelzoo; provided, that the Board determined that Mr. Karg would not be considered an “executive officer” of Mindshare as defined under the Securities Exchange Act of 1934 and that any amounts paid by any member of the WPP Group to Travelzoo or by Travelzoo to any member of the WPP Group over the past three years are not material. Such relationships and amounts will continue to be monitored going forward. Mr. Karg also confirmed that in his role as Global Chief Operating Officer he does not have any input into client relationships or media spend and does not receive any compensation from clients or for the performance of clients. The Board therefore determined that no conflict of interest exists pursuant to the Company’s Code of Ethics. The Board determined that Mr. Holger Bartel is not independent under the rules of NASDAQ because he is an employee of the Company. The Board determined that Ms. Christina Sindoni Ciocca is not independent under the rules of NASDAQ because she is an employee of the Company.
Holger Bartel, Ph.D., has been Travelzoo’s Global Chief Executive Officer since January 2016. From July 2010 to May 2017, he was the Chairman of the Board of Directors. From September 2015 to December 2015, he was Travelzoo’s Executive Chairman. From October 2011 to October 2013, he was Head of Strategy. Mr. Bartel holds a Ph.D. in Economics and an MBA in finance and accounting from the University of St. Gallen, Switzerland. He is the brother of Mr. Ralph Bartel.
6

TABLE OF CONTENTS

Areas of Mr. Bartel’s relevant experience include deep knowledge of Travelzoo's operations, Internet, strategy, management of growth companies, travel and international management.
Christina Sindoni Ciocca has been a member of Travelzoo’s Board since May 2019 and has been serving as Corporate Secretary and, since December 2022, as the Chair of the Board. She has been General Counsel and Head of Global Functions for Travelzoo since April 1, 2022 and General Counsel since June 2019. Ms. Ciocca previously served as Counsel for Travelzoo since April 2018. Prior to joining Travelzoo, Ms. Ciocca was an attorney at Sidley Austin LLP, practicing in mergers & acquisitions in both Chicago, IL and New York, NY, from September 2014 to March 2018. Ms. Ciocca earned her juris doctor degree from the Law School of the University of Notre Dame and a Bachelor of Science in Economics degree from the Wharton School of the University of Pennsylvania, with concentrations in marketing and operations & information management. Prior to law school, Ms. Ciocca worked in digital marketing, including for American Express.
Areas of Ms. Ciocca’s relevant experience include corporate governance, law, mergers & acquisitions and marketing.
Carrie Liqun Liu has been a member of Travelzoo's Board since May I obtain2017. She is the Vice General Manager of Beijing Science & Technology Innovation Fund and has been since 2019. Before that she was the General Manager of the Private Equity Business at Tianhong, a listprominent fund management company in China. From July 2011 to May 2017, Ms. Liu was the Executive Director of Fosun China Momentum Fund. From May 2009 to July 2011, she was a senior investment professional at Henderson Equity Partners. From 2015 to 2016, she was a member of the board of directors and audit committee of Tom Tailor Holding AG, and also a member of the board of directors of Cirque du Soleil, an entertainment company. Ms. Liu holds a bachelor’s degree in finance and master’s degree in law from Tsinghua University in Beijing, China.
Areas of Ms. Liu’s relevant experience include Asian markets, investments, finance and global strategy.
Michael Karg, Ph.D., is the Global Chief Operating Officer of Mindshare and has been since November 2021. From January 2016 to December 2019, he was the Group Chief Executive Officer of Ebiquity plc, a company listed on the London stock exchange (AIM). From May 2013 to December 2015, he was the Chief Executive Officer International of Razorfish. From September 2011 to May 2013, Mr. Karg was the President EMEA for Razorfish and Digitas International in Paris. From September 2010 to May 2013, he was also the Chief Operating Officer of Razorfish and Digitas International. From 2013 to 2017, Mr. Karg served as a member of the board of directors of Travelzoo. Mr. Karg holds a Ph.D. in management and a master’s equivalent in finance and accounting from the University of St. Gallen, Switzerland.
Areas of Mr. Karg’s relevant experience include digital media and global operations.
Volodymyr Cherevko is the Chief Transformation Officer of Haier Europe and has been since September 2021. Before that he was the General Manager & Managing Director, Washing Business Unit, for Haier Europe in Paris. From October 2015 to October 2017 he was the Product Marketing Director, Refrigeration, for Whirlpool EMEA in Italy. From January 2014 to October 2015 Mr. Cherevko was the Marketing Director & Department Head, Brands, Digital, e-Commerce & Insights for Whirlpool EMEA. Before that, Mr. Cherevko held a variety of marketing roles for Procter & Gamble and PepsiCo in Kyiv and Moscow. Mr. Cherevko holds an Executive MBA from HEC Paris, executive certificate from INSEAD and a Bachelor of Arts in business administration from Bethany Lutheran College.
Areas of Mr. Cherevko’s relevant experience include marketing and business transformation.
Required Vote
Our Certificate of Incorporation, as amended, does not authorize cumulative voting. Delaware law and our Amended and Restated By-laws provide that directors are to be elected by a majority of the votes cast at the Annual Meeting by the holders of stock entitled to vote on the election of directors; provided, however, that, if the Corporate Secretary determines that the number of nominees for director exceeds the number of directors to be elected, directors shall be elected by a plurality of the votes of the shares represented in person or by proxy at any meeting of stockholders entitledheld to attendelect directors and vote at the special meeting?

Travelzoo will make available an alphabetical list of stockholders entitled to vote on such election of directors. A majority of the votes cast means that the number of shares voted “for” a nominee must exceed the votes cast “against” such nominee’s election. The following shall not be votes cast: (a) a share whose ballot is marked as withheld; (b) a share otherwise present at the meeting but for which there is an abstention; and (c) a share otherwise
7

TABLE OF CONTENTS

present at the meeting for examinationwhich a shareholder gives no authority or direction. Thus, abstentions and broker non-votes will have no effect on the election of directors (other than the fact that they are counted for the purpose of determining whether a stockholder quorum exists at the Annual Meeting). Proxies cannot be voted for a greater number of persons than the number of nominees named.
The Board's Recommendation
The Board believes that each director nominee possesses the qualities and experience a member of Travelzoo's Board should possess. The Board seeks out, and the Board is comprised of, individuals whose background and experience complement those of other Board members.
THE BOARD RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” THE ELECTION OF THE FIVE DIRECTOR NOMINEES NAMED ABOVE.
8

TABLE OF CONTENTS

CORPORATE GOVERNANCE
Board Meetings and Committees
The Board has appointed an Audit Committee, a Compensation Committee, a Disclosure Committee and a Nominating and Corporate Governance Committee. Below is a table indicating the membership of each committee and how many times the Board and each such committee met in fiscal year 2022. Beginning in 2021, the Board voted to change membership in the Disclosure Committee to management only in line with corporate governance best practices. Each Board member attended at least 75 percent of the total number of meetings of the Board and of the committees on which he or she served.
Name
Board
Audit
Compensation
Nominating and
Corporate
Governance
Mr. Ralph Bartel
Chair
 
 
 
Ms. Christina Sindoni Ciocca
Secretary
 
 
 
Ms. Carrie Liqun Liu
Member
Member
 
 
Mr. Michael Karg
Member
Chair
Member
Member
Mr. Volodymyr Cherevko
Member
Member
Chair
Chair
Number of 2022 Meetings
4
4
1
2
The Company does not require that directors attend the Annual Meeting of Stockholders. Note, Mr. Michael Karg and Mr. Volodymyr Cherevko replaced Ms. Mary Reilly and Ms. Beatrice Tarka on April 28, 2022 upon election by the stockholders at last year’s annual meeting. Therefore, Ms. Reilly and Ms. Tarka attended the Board and Committee meetings that took place during Q1 2022 and Mr. Karg and Mr. Cherevko attended the Board and Committee meetings that took place from Q2 2022 through to the end of the year. Ms. Reilly previously served as the Chair of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Mr. Karg now serves as the Chair of the Audit Committee and Mr. Cherevko serves as the Chair of the Compensation Committee and Nominating and Corporate Governance Committee.
Audit Committee
The Audit Committee is appointed by the Board to discharge the Board’s responsibilities with respect to among other things, (i) the Company’s accounting and financial reporting processes; (ii) audits of the financial statements of the Company; and (iii) the qualifications, independence and performance of the Company’s independent auditors. A complete description of the Audit Committee's responsibilities is set forth in its written charter. A copy of the Amended and Restated Audit Committee Charter, which was adopted by the Board on March 22, 2019, can be found in Appendix A of our 2019 proxy statement. The Audit Committee is responsible for appointing the independent registered public accounting firm and is directly responsible for the compensation and oversight of the work of our independent registered public accounting firm. The Audit Committee is composed solely of independent directors as defined in the listing standards of the NASDAQ Stock Market, the SEC, the Sarbanes-Oxley Act of 2002 and any stockholder during ordinarysuccessor rules or regulations. The Board determined that Mr. Michael Karg qualifies as an audit committee financial expert within the meaning of SEC regulations.
Compensation Committee
The Compensation Committee is appointed by the Board to discharge the Board’s responsibilities with respect to, among other things, the evaluation, approval and administration of the Company’s compensation and incentive plans, policies and programs for executive officers and directors of the Company. A complete description of the Compensation Committee’s responsibilities is set forth in its written charter. A copy of the Compensation Committee Charter, which was adopted by the Board on March 22, 2019, can be found in Appendix A of our 2019 proxy statement.
Disclosure Committee
The Disclosure Committee's primary responsibilities are (i) to design, establish and evaluate controls and other procedures that are designed to ensure the accuracy and timely disclosure of information to the SEC and investment community and (ii) to review and supervise preparation of SEC filings, press releases and other broadly disseminated correspondence. Originally, the Disclosure Committee included two members of the Board,
9

TABLE OF CONTENTS

but at the Q1 2021 Board meeting, the directors voted to change the Disclosure Committee to a management committee, reporting directly to the Global Chief Executive Officer and Chief Accounting Officer or Chief Financial Officer, as applicable, and providing updates to the Audit Committee as necessary, in line with corporate governance best practices.
Nominating and Corporate Governance Committee
The Nominating and Corporate Governance Committee assists the Board in identifying qualified individuals to become directors, makes recommendations to the Board concerning the size, structure and composition of the Board and its committees, monitors the process to assess the Board’s effectiveness and is primarily responsible for oversight of corporate governance. In evaluating potential nominees to the Board, the Nominating and Corporate Governance Committee considers, among other things, independence, character, ability to exercise sound judgment, age, demonstrated leadership, skills, including financial literacy, and experience in the context of the needs of the Board. The Nominating and Corporate Governance Committee considers candidates proposed by shareholders and evaluates them using the same criteria as for other candidates. The Nominating and Corporate Governance Committee recommended to the full Board each of the current nominees for election to the Board.
The Board's Role in Risk Oversight
The full Board oversees enterprise risk as part of its role in reviewing and overseeing the implementation of the Company's strategic plans and objectives. The risk oversight function is administered both in full Board discussions, informal meetings and in individual committees that are tasked by the Board with oversight of specific risks. On a regular basis, the Board and its committees receive information and reports from management on the status of the Company and the risks associated with the Company's strategy and business hoursplans. In addition, the Audit Committee reviews the Company's risk assessment and risk management policies and procedures at Travelzoo’s office,least annually, including steps taken to monitor and control such exposures. The Board believes the continuity of Board membership and the independent directors constituting a majority of the Board encourage open discussion and assessment of the Company's ability to manage its risks.
Code of Ethics
We have adopted a Code of Ethics that applies to our executive officers, including, but not limited to our Global Chief Executive Officer and our Chief Accounting Officer or Chief Financial Officer, as applicable. This Code of Ethics is posted on our website located atcorporate.travelzoo.com/governance. A copy of the Code of Ethics is also available in print to stockholders and interested parties without charge upon written request delivered to our Corporate Secretary at Travelzoo, 590 Madison Avenue, 35th Floor, New York, NY 10022, for ten days prior to the meeting. A stockholder may examine the list for any legally valid purpose related to the meeting.10022.



12



RISK FACTORS

In addition to the other information included or incorporated by reference in this proxy statement, including the matters addressed in the section of the proxy statement entitled “Cautionary Statement Concerning Forward-Looking Information,” you should carefully consider the following risks before deciding how to vote on the proposals presented at the special meeting. The risk factors related to the Issuance present the material risks directly related to the Issuance and the Merger presently known to us. We have also included the material risks associatedCommunications with the business of MTE presently known to us, because these risks will also affect the Company following the consummation of the Merger. The risks below also include forward-looking statements, and our actual results may differ substantially from those discussed in these forward-looking statements. See section “Cautionary Statement Concerning Forward-Looking Information” below.

Risk Factors Related to the Issuance and the Merger

Current stockholders will have reduced ownership and voting interests after the Issuance.

We will issue to Azzurro in the Issuance new shares of common stock that account for approximately 27.5% of our shares of common stock outstanding prior to the Issuance. When the Issuance occurs, Azzurro will have ownership of more than 50% of the Company. As a result, the percentage ownership of the Company held by each of our current stockholders will be smaller than such stockholder’s percentage ownership of the Company prior to the Issuance. Our current stockholders will, therefore, have proportionately less ownership and voting interests in the Company following the Issuance than they have now. In addition, if the value of the Shares is less than the value of the Company, then our existing stockholders will experience dilution in the value of their shares of common stock.

Directors
The market price of our common stock may decline asBoard has established a result of the Issuance.

We currently anticipate that the Issuance and the Merger will be accretiveprocess to earnings per share, after factoring in synergies and excluding costs to achieve synergiesreceive communications from stockholders. Stockholders and other one-time costs related to the Issuance. This expectation is based on preliminary estimates that are subject to change. We could also encounter additional transaction and integration-related costs,interested parties may fail to realizecontact any member (or all of the benefits anticipated in the Issuance and the Merger, including the utilization of the NOLs, or be subject to other factors that affect preliminary estimates. Any of these factors could cause a decrease in our adjusted earnings per share or decrease the expected accretive effect of the Issuance and the Merger and contribute to a decrease in the price of our Common Stock.

Azzurro will have significant influence over the Company following the consummation of the Issuance, and its interests may conflict with ours or yours in the future.

Before the consummation of the Issuance, Azzurro and its affiliates hold approximately 36.26% of the Company’s Common Stock. Following the consummation of the Issuance, Azzurro and its affiliates would hold greater than 50% of the Company’s Common Stock. While we expect this ownership structure will allow the Company, pursuant to the applicable tax regulations, to potentially fully utilize the outstanding NOLs of MTE, it will mean that the Company is a controlled company again. Azzurro previously held greater than 50% ownership up until 2018. The Company already has in place applicable corporate governance processes and procedures required and necessary for a controlled company to ensure independence (e.g., a Board with majority independent directors, a compensation and audit committee comprised solely of independent directors, etc.).

Although the structuremembers) of the Board, will not changeor the non-management directors as a group, any Board committee or any chair of any such committee by mail. To communicate with the Issuance, it is possible that the interestsBoard, any individual director or any group or committee of Azzurro and its affiliates may conflict with those of the Company or yours as stockholders of the Company in the future. In addition, in light of Azzurro’s majority ownership of the Company, Azzurro willdirectors, correspondence should be able to approve or otherwise exert significant influence over other corporate transactions.Our other stockholders will therefore have limited influence and control on matters requiring stockholder approval.

The Company has and expects to incur substantial costs relatedaddressed to the Issuance and the Merger.Board or any such individual director or group or committee of directors by either name or title. All such correspondence should be sent to “c/o Corporate Secretary” at Travelzoo, 590 Madison Avenue, 35th Floor, New York, NY 10022.

We have incurred and may continue to incur a number of non-recurring costs associated with the Issuance and related transactions. These costs include legal, financial advisory, accounting, consulting and other advisory fees, closing, integration and other related costs. Some of these costs are payable regardless of whether or not the Issuance is completed.



13


Failure to consummate the Issuance could negatively impact our business, financial condition, results of operations or stock prices.

Consummation of the Issuance is conditioned upon the satisfaction of certain closing conditions, including the approval of the Issuance by our stockholders,All communications received as set forth in the Stock Purchase Agreement. The required conditionspreceding paragraph will be opened by the Corporate Secretary for the sole purpose of determining whether the contents represent a message to closing mayour directors. Any contents that are not in the nature of advertising, promotions of a product or service, patently offensive material or matters deemed inappropriate for the Board will be satisfied in a timely manner, if at all, or they may be waived. Ifforwarded promptly to the transaction is not consummated for theseaddressee. In the case of communications to the Board or any other reasons, our ongoing business may be adversely affected andgroup or committee of directors, the Corporate Secretary will be subject to a number of risks and consequences, including the following:

we must pay the substantial fees and expenses we incurred related to the Issuance, such as legal, accounting, printing and planning fees and expenses, even if the Issuance is not consummated;
matters relating to the Issuance and the Merger may require substantial commitments of time and resources by our management, which could otherwise have been devoted to other opportunities that may have been beneficial to us;
the market price of our Common Stock may decline to the extent that the current market price reflects a market assumption that the Issuance will be consummated;
we may experience negative reactions to the termination of the Issuance from customers, clients, business partners, lenders and employees; and
we would not realize any of the anticipated benefits of having consummated the Issuance or the Merger

In addition, any delay in the consummationmake sufficient copies of the Issuance and the Merger, or any uncertainty about the consummationcontents to send to each director who is a member of the Issuance, may adversely affect our future business, growth, revenue, and results of operations.group or committee to which the correspondence is addressed.
10
The Issuance and the Merger may be more difficult, costly, or time-consuming than expected, and we may not realize the anticipated benefits of the Merger, including full utilization of the NOLs.


TABLE OF CONTENTS

Director Compensation
The various legal requirements of the Issuance and Merger, including compliance with the Code, SEC regulations, Delaware law, New York law, etc., have meant that the Company has had to expend significant time and resources, including by its internal management team and external advisors. The Issuance and the Merger have already been under consideration by the Company for multiple years. If the Issuance and the Merger were not consummated or continued to take more time for review and compliance with various legal requirements, it could result in the anticipated benefits of the Merger not being worth the ongoing costs, both in terms of money spent on external advisors (legal, financial, tax, etc.) and distraction of management.

To realize the anticipated benefits from the Issuance and the Merger, the Company must meet the various requirements of the Code. Although the Company’s tax advisor, Grant Thornton, has reviewed the transaction structure in detail, it is possible that the Company may be audited upon utilization of the NOLs and that the Internal Revenue Service may disagree with Grant Thornton’s analysis and the Company’s position, resulting in a limitation on the utilization of the NOLs and/or the inabilityDirectors of the Company or its subsidiaries are entitled to utilizereceive certain retainers and fees as determined by the NOLs at all. Although the Company has remained conservative in its estimatesBoard based on recommendations of the impactCompensation Committee. In 2021, the Compensation Committee recommended that the Board change director compensation as follows: (a) increase the fee earned for Board meetings to $2,800 from $1,680, (b) decrease the fee earned for Compensation Committee meetings to $1,680 from $2,800, (c) change the Disclosure Committee to an executive-only committee in line with corporate governance best practices so no fee is payable for those meetings, and (d) include a fee for Special Committee meetings, if and when a Special Committee is appointed, of $5,000 for up to five (5) meetings or $8,000 for up to ten (10) meetings. The retainers and meeting fees are as follows:
Description
Fee
Earned ($)
Annual retainer for each Board member
50,000
Annual retainer for Audit Committee Chair
30,000
Fee for attendance of a Board meeting
2,800
Fee for attendance of an Audit Committee meeting
2,800
Fee for attendance of a Compensation Committee meeting
1,680
Fee for attendance of Special Committee meetings (total fee for up to 5 meetings)
5,000
Fee for attendance of Special Committee meetings (total fee for up to 10 meetings)
8,000
Members of the IssuanceBoard may receive fees for additional meetings and committee work and may receive stock option grants on an ad hoc basis in the Merger ondiscretion of the Company once consummated,Compensation Committee.
We reimburse directors for out-of-pocket expenses incurred in connection with attending meetings. No travel was required for meetings of the Company would planBoard in 2022.
Employees generally do not receive compensation for their services as directors. Accordingly, Ms. Christina Sindoni Ciocca did not receive any compensation for her service as a member of the Board in 2022. Although not an employee, Mr. Ralph Bartel waived board fees to applyhim in 2022.
The following table shows the NOLs on its tax returns, including for the tax year ended December 31, 2022, and if the Company was not able to do this, it would lose a substantial benefit and would require a shiftfees earned or paid in cash forecasting and tax planning, which would expend additional resources.

The Stock Purchase Agreement may be terminated in accordance with its terms and the Issuance and the Merger may not be completed.

The Stock Purchase Agreement is subject to a number of conditions that must be fulfilled in order to complete the Issuance and the Merger. Those conditions include approval of the Issuance Proposal by our stockholders, and the absence of any statute, rule, regulation, order or other notice (whether temporary, preliminary or permanent) that is enacted, issued, promulgated, enforced or entered which is in effect and which prevents or prohibits consummation of the transactions. Each party’s obligation to complete the Issuance is also subject to certain additional customary conditions. These conditions to the closing may not be fulfilled in a timely manner or at all, and, accordingly, the Issuance may not be completed.


14


Our estimates and judgments related to the acquisition accounting methods used to record the purchase price allocation related to the acquisition of MTE may be inaccurate.

Our management will make significant accounting judgments and estimates related to the application of acquisition accounting of the Merger under GAAP, as well as the underlying valuation models. Our business, operating results, and financial condition could be materially adversely impacted in future periods if the accounting judgments and estimates prove to be inaccurate.

Any delay in completing the Issuance may reduce or eliminate the benefits expected to be achieved thereafter.

In addition to the required stockholder approval, the Issuance and the Merger are subject to a number of other conditions beyond our control that may prevent, delay, or otherwise materially adversely affect its consummation. We cannot predict whether and when these other conditions will be satisfied. Any delay in completing the Issuance and the Merger could cause us not to realize some or all of the synergies and other benefits that we expect to achieve if the Issuance and the Merger are successfully consummated within its expected time frame, including tangible tax benefits for the tax year ending on December 31, 2022.

If we are unable to effectively manage MTE’s and our Metaverse business, our reputation and operating results may be harmed.

Following the Issuance and the Merger, we will need to integrate the Metaverse scouting business into the business of the Company and Travelzoo META. As the landscape of the Metaverse is continually shifting, we may be unable to successfully integrate the Metaverse sourcing business with the contemplated Travelzoo META membership. If we are unable to do so for any reason, our reputation and operating results may be harmed and we would be unable to realize the business-related benefits of the transaction.

We face a number of additional risks related to the operations of our business.

You should carefully consider each of the risk factors set forth in our filings with the SEC, including our Annual Report on Form 10-KTravelzoo’s directors for the fiscal year ended December 31, 20212022.
Name
Fees
Earned
or Paid in
Cash($)(1)
Stock
Awards
($)(2)
Total
($)(3)(4)
Mr. Ralph Bartel
Ms. Christina Sindoni Ciocca
Ms. Carrie Liqun Liu
77,400
77,400
Ms. Mary Reilly
28,960
28,960
Ms. Beatrice Tarka
21,460
21,460
Mr. Michael Karg
76,305
76,305
Mr. Volodymyr Cherevko
55,866
55,866
(1)
This column reports the amount of cash compensation earned in 2022 for Board and committee service.
(2)
Mr. Ralph Bartel had 200,000 vested options outstanding as of April 14, 2023.
(3)
Amounts included in this table do not include compensation received by Ms. Ciocca for her role as General Counsel and Head of Global Functions of the Company, including 100,000 stock options granted in March 2020 and approved by the shareholders at the 2020 Annual Meeting and an additional 200,000 stock options granted in March 2023, subject to approval by the shareholders at the 2023 Annual Meeting, as set forth in this proxy statement.
(4)
Mr. Michael Karg and Mr. Volodymyr Cherevko joined the Board in Q2 2022, when Ms. Mary Reilly and Ms. Beatrice Tarka rotated off due to long tenure.
11

TABLE OF CONTENTS

Board Diversity Matrix
The following is the Board Diversity Matrix for the Company as of April 14, 2023 in evaluatingcompliance with NASDAQ’s Board Diversity Rule:
 
Female
Male
Total Number of Directors
5
Part I: Gender Identity
 
 
Directors
2
3
Part II: Demographic Background
 
 
Asian (other than South Asian)
1
0
White
3
1
Certain Relationships and Related Party Transactions
The Company maintains policies and procedures to ensure that our directors, executive officers and employees avoid conflicts of interest. Our executive officers, including our Global Chief Executive Officer and Chief Accounting Officer or Chief Financial Officer, as applicable, are subject to our Code of Ethics. Our Code of Ethics requires our leadership to act with honesty and integrity, and to fully disclose to the Audit Committee any material transaction that reasonably could be expected to give rise to an actual or apparent conflict of interest. The Code of Ethics requires that our leadership obtain the prior written approval of the Audit Committee before proceeding with or engaging in any conflict of interest. Moreover, employees are required to read and comply with our Guide to Business Conduct, which is a communication to all employees that ensures they are aware of their responsibility to avoid any conflicts of interest or potential conflicts of interest and to make appropriate disclosures to their manager or other personnel.
Our General Counsel and/or Chief Accounting Officer or Chief Financial Officer, as applicable, review(s) all material related party transactions. When a potential related party transaction is identified, the General Counsel and/or the Chief Accounting Officer or Chief Financial Officer, as applicable, will evaluate the transaction and determine whether the transaction requires the review and approval by the Audit Committee or a special committee of the Board consisting of independent directors (“Special Committee”).
The Audit Committee charter states that the Audit Committee has the duty and responsibility to review and approve in advance, to the extent possible, any proposed related party transactions and potential conflict of interest situations involving a director or director nominee of the Company, an executive officer of the Company, any person or entity known by the Company to be a beneficial owner of more than 5% of the Company’s Common Stock, or any person known by the Company to be an immediate family member of any of the foregoing; provided, that the Audit Committee shall have the authority to ratify certain related party transactions if approval of such transactions in advance is not practicable or possible, in the sole discretion of the Committee. A copy of the written charter can be found in Appendix A to the 2019 proxy statement.
Upon submission to the Audit Committee or a Special Committee, such committee will consider relevant facts and circumstances surrounding each related party transaction and any matters the committee deems appropriate. If the Audit Committee or a Special Committee determines that any such related party transaction creates a conflict of interest situation or would require disclosure under Item 404 of Regulation S-K, as promulgated by the SEC, the transaction must be approved by the committee prior to the Company entering into such transaction or ratified thereafter. Transactions or relationships previously approved by the Audit Committee or a Special Committee in existence prior to the formation of the committee do not require approval or ratification.
Ralph Bartel, who founded Travelzoo and who was previously a director of the Company, is the sole beneficiary of the Ralph Bartel 2005 Trust, which is the controlling shareholder of Azzurro Capital Inc. As of April 14, 2023, Azzurro Capital Inc. is the Company's largest stockholder, holding approximately 49% of the Company's outstanding shares. Ralph Bartel, as an individual, holds approximately 1% of the Company’s outstanding shares.
Family Relationships
Ralph Bartel, founder of Travelzoo, and Holger Bartel, Global Chief Executive Officer, are brothers. Except for Holger Bartel and Ralph Bartel, there are no familial relationships among any of our officers and directors.
12

TABLE OF CONTENTS

Involvement in Certain Legal Proceedings
To our knowledge, during the last ten years, none of our directors and executive officers have: (i) had a bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time; (ii) been convicted in a criminal proceeding or been subject to a pending criminal proceeding, excluding traffic violations and prospects. other minor offenses; (iii) been subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities; (iv) been found by a court of competent jurisdiction (in a civil action), the SEC, or the Commodities Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated; or (v) been the subject to, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization, any registered entity, or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.
13

TABLE OF CONTENTS

INFORMATION ABOUT OUR EXECUTIVE OFFICERS
The risksfollowing table sets forth certain information with respect to the named executive officers of Travelzoo, as determined by the Compensation Committee, as of April 14, 2023.
Name
Age
Position
Holger Bartel, Ph.D.
55
Global Chief Executive Officer
Christina Sindoni Ciocca
35
General Counsel and Head of Global Functions
Holger Bartel, Ph.D., has been Travelzoo's Global Chief Executive Officer since January 2016. From July 2010 to May 2017, he was the Chairman of the Board. From October 2011 to October 2013, he was the Head of Strategy. From October 2008 to June 2010, he was Travelzoo's Chief Executive Officer. From September 1999 to November 2007, he was Executive Vice President. From 1995 to 1998, he was Engagement Manager at McKinsey & Company, a global management consulting firm. From 1992 to 1994, he was a research fellow at Harvard Business School. Mr. Holger Bartel holds a Ph.D. in economics and uncertainties describedan MBA in finance and accounting from the University of St. Gallen, Switzerland. He is the brother of Ralph Bartel, the founder of Travelzoo.
Christina Sindoni Ciocca has been with Travelzoo since April 2018. She has been a member of Travelzoo’s Board since May 2019 and has been serving as Corporate Secretary and, since December 2022, as the Chair of the Board. She has been General Counsel and Head of Global Functions for Travelzoo since April 1, 2022 and General Counsel since June 2019. Ms. Ciocca previously served as Counsel for Travelzoo since April 2018. Prior to joining Travelzoo, Ms. Ciocca was an attorney at Sidley Austin LLP, practicing in mergers & acquisitions in both Chicago, IL and New York, NY, from September 2014 to March 2018. Ms. Ciocca earned her juris doctor degree from the Law School of the University of Notre Dame and a Bachelor of Science in Economics degree from the Wharton School of the University of Pennsylvania, with concentrations in marketing and operations & information management. Prior to law school, Ms. Ciocca worked in digital marketing, including for American Express.
Note, Mr. Wayne Lee, who was providing consulting services as the Company’s Chief Financial Officer pursuant to a six-month agreement that was extended by mutual agreement for one month, left the Company on March 31, 2023, as set forth in the Form 8-K filed on April 6, 2023. In the interim period as the Company recruits for a new Chief Financial Officer, Ms. Lijun Qi, Finance Director, was appointed as the Company’s principal accounting officer. Per the determination of the Board, Ms. Qi qualifies as an officer pursuant to Section 16 of the Exchange Act, but is not considered a named executive officer, and therefore is not included as such in this proxy statement.
14

TABLE OF CONTENTS

PROPOSAL 2—APPROVAL OF OPTION GRANT TO THE GENERAL COUNSEL AND
HEAD OF GLOBAL FUNCTIONS
Option Agreement with the General Counsel and Head of Global Functions
The Company entered into a Nonqualified Stock Option Agreement (the “Option Agreement”) with Ms. Christina Sindoni Ciocca, General Counsel and Head of Global Functions, on March 8, 2023, pursuant to which the Company granted Ms. Ciocca the option to purchase 200,000 shares of the Company’s common stock (such option being hereinafter referred to as the “Option”). The first tranche of the Option shall vest on June 30, 2023 and will not be exercisable unless and until the stockholders approve. Stockholders are being asked to approve the issuance of Common Stock which is issuable to Ms. Ciocca upon exercise of the Option.
The principal terms of the Option Agreement are summarized below. The following summary is qualified in its entirety by the full text of the Option Agreement, which is incorporated by reference herein by reference to Appendix A to this proxy statement.
The Compensation Committee engaged an independent compensation consultant, Compensia, to advise on Ms. Ciocca’s compensation package, including base salary, bonus, if applicable, and option grant. The Compensation Committee, which is comprised solely of independent directors, unanimously approved the Option and the Option Agreement after confirming that both were generally in line with historical practices of the Company, specifically the four-year term, or market practice, specifically the bi-annual vesting schedule, as well as the total amount and value of the grant.
Exercisability of Option
The exercise price of the Option is $4.96 per share. The Option will become exercisable in accordance with the following schedule:
Vesting Date
Percentage of
Option Vesting
On June 30, 2023
12.5%
On December 31, 2023
12.5%
On June 30, 2024
12.5%
On December 31, 2024
12.5%
On June 30, 2025
12.5%
On December 31, 2025
12.5%
On June 30, 2026
12.5%
On December 31, 2026
12.5%
Ms. Ciocca must exercise the Option by March 8, 2028; after such date, the Option will expire.
Exercise of Option
Ms. Ciocca may exercise, in whole or in part, the Option by delivering to the Company (a) not less than 30 days prior to the exercise date (or such shorter period as the Company may approve) a written notice (email being acceptable) of intent to exercise and estimated date of exercise and (b) not less than five (5) business days prior to the date of exercise (or such shorter period as the Company may approve) (i) written notice of exercise, designating the number of shares to be purchased, and (ii) payment of the full amount of the purchase price of the shares being purchased and payment of the full amount of applicable taxes triggered by the exercise of the option and shares being purchased.
The Option may not be exercised if shareholder approval is not received and may not be exercised prior to the registration of the shares being offered under the Option Agreement, which registration shall be filed by the Company with the SEC following the Company’s annual shareholder meeting, so long as approval has been obtained.
Adjustment of Option
As is customary in stock option agreements of this nature, the number of shares subject to the Option and exercise price are subject to adjustment in the event there is any change in the number of shares of outstanding common stock of the Company by reason of a stock dividend, recapitalization, merger, consolidation, split-up, combination, exchange of shares or other similar event.
15

TABLE OF CONTENTS

Transfer Restrictions
The Option is not transferable by Ms. Ciocca other than by will or the laws of descent and distribution and may be exercised during Ms. Ciocca’s lifetime only by her or her guardian or legal representative.
Effect of Termination of Employment
If Ms. Ciocca’s employment with the Company is terminated, including in the event of her death or disability, any portion of the Option which is not then exercisable will immediately terminate. With respect to any portion of the Option which is then exercisable on the date of termination of employment, Ms. Ciocca (or, in the event of her death, her legatee(s) under her last will, or her personal representatives or distributees) may exercise such portion of the Option for a period of 90 days following such termination, but in no event after March 8, 2028.
Personal Interest
Ms. Christina Sindoni Ciocca is Travelzoo’s General Counsel and Head of Global Functions as well as the Chair of Travelzoo’s Board and its Corporate Secretary. Ms. Ciocca is also currently acting as the Chief Executive Officer of JFC Travel Group Co.
The Board’s Recommendation
THE COMPENSATION COMMITTEE ON BEHALF OF THE BOARD UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THIS PROPOSAL RELATING TO THE OPTION AGREEMENT.
16

TABLE OF CONTENTS

PROPOSAL 3—ADVISORY VOTE ON THE FREQUENCY OF SAY-ON-PAY VOTES
Section 14A of the Exchange Act requires that once every six years the Company include a non-binding stockholder vote to advise on whether the frequency of the Say-on-Pay (as defined below) vote should occur every one, two or three years. You have the option to vote for any one of the three options, or to abstain on the matter.
The Compensation Committee of the Board has determined that an annual advisory vote on executive compensation is the best approach for the Company. In formulating its recommendation, the Compensation Committee considered that an annual advisory vote on executive compensation will allow stockholders to provide direct input on the Company’s compensation philosophy, policies and practices every year. Additionally, an annual advisory vote on executive compensation is consistent with the Company’s policy of seeking input from, and engaging in discussions with, its stockholders on executive compensation and corporate governance matters.
The option receiving the greatest number of votes (every one, two or three years) will be considered the frequency approved by stockholders. Although the vote is non-binding, the Board of Directors will take into account the outcome of the vote when making future decisions about the frequency for holding an advisory vote on executive compensation.
The Board’s Recommendation
THE BOARD RECOMMENDS A VOTE ON PROPOSAL 3 TO HOLD SAY-ON-PAY VOTES EVERY 1 YEAR (AS OPPOSED TO EVERY 2 YEARS OR EVERY 3 YEARS). A PLURALITY OF THE VOTES WILL DETERMINE THE SHAREHOLDERS' PREFERRED FREQUENCY FOR HOLDING AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. THIS MEANS THAT THE OPTION FOR HOLDING AN ADVISORY VOTE EVERY 1 YEAR, 2 YEARS, OR 3 YEARS RECEIVING THE GREATEST NUMBER OF VOTES WILL BE CONSIDERED THE PREFERRED FREQUENCY OF THE SHAREHOLDERS.
17

TABLE OF CONTENTS

PROPOSAL 4—ADVISORY VOTE ON EXECUTIVE COMPENSATION
Section 14A of the Exchange Act requires that we include in this proxy statement area non-binding stockholder vote on our executive compensation as described herein (commonly referred to as “Say-on-Pay”).
The design of our executive compensation program is not a mechanical process, and our Board uses its judgment and experience and works with our Compensation Committee to determine the only ones we face. Additional risksappropriate mix of compensation for each individual. Additionally, the Compensation Committee has engaged an independent compensation consultant, Compensia, to advise on executive compensation. Please read the Executive Compensation section for additional details.
The Board of Directors and uncertainties not presently known to us orthe Compensation Committee strongly endorse the Company's executive compensation program and unanimously recommend that we currently consider immaterial may also impair our business operations. If anystockholders vote in favor of the risks actually occur,following resolution:
RESOLVED, that the stockholders approve, by an advisory vote, the compensation of our named executive officers, as disclosed pursuant to the compensation disclosure rules of the SEC, including the Executive Compensation section and the other tabular and narrative disclosure in the Company's proxy statement for its 2023 Annual Meeting of Stockholders.
Required Vote
Because the vote is advisory, it will not be binding upon the Board or the Compensation Committee and neither the Board nor the Compensation Committee will be required to take any action as a result of the outcome of the vote on this proposal. The Compensation Committee will consider the outcome of the vote when considering future executive compensation arrangements. The affirmative vote of the majority of the shares of the Company’s Common Stock present in person or represented by proxy and entitled to vote on the proposal will be considered as the approval, by an advisory vote, of the compensation of our named executive officers.
The Board’s Recommendation
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THE ADVISORY RESOLUTION RELATING TO THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
18

TABLE OF CONTENTS

EXECUTIVE COMPENSATION
Overview of Compensation Program
The following Executive Compensation discussion describes our overall compensation philosophy and the primary components of our compensation program. Furthermore, the Executive Compensation discussion explains the process by which the Compensation Committee, or “Committee”, determined the 2022 compensation for our Global Chief Executive Officer, former Chief Financial Officer, former Chief Accounting Officer and General Counsel and Head of Global Functions. We refer to these individuals collectively as the “named executives” or the “named executive officers”.
Compensation Philosophy and Objectives
The fundamental objectives of our executive compensation program are to attract and retain highly qualified executive officers, motivate these executive officers to materially contribute to our long-term business success, and align the interests of our executive officers and stockholders by rewarding our executives for individual and corporate performance based on targets established by the Committee.
We believe that achievement of these compensation program objectives enhances long-term profitability and stockholder value. Although we consider a number of factors in our pay decisions, the elements utilized to guide the Committee to help it achieve its objectives include the following:
Accountability for Individual Performance. Compensation should in large part depend on the named executive's individual performance in order to motivate and acknowledge the key contributors to our success.
Fairness. The Company should take a consistent approach to pay practices in order to achieve pay equity across gender, race and ethnicity, and should seek independent advice when needed to ensure alignment with the market environment.
Recognition for Business Performance and Innovation. Compensation should take into consideration the Company's overall financial results couldperformance and growth, as well as any initiatives that can bring transformation to the Company.
Attracting and Retaining Talented Executives. Compensation should generally reflect the competitive marketplace and be harmed.designed to attract and retain superior employees in key competitive positions.
Changing Market Conditions. Compensation should take into consideration the constantly evolving market environment in which the Company operates, including, for example, recovery from the global pandemic.
We implement our compensation philosophy through setting base salaries for our executive officers based on market research, providing bonus opportunities when appropriate for the executive’s role, granting stock options to certain key employees when appropriate and reviewing and approving other terms of employment agreements as needed and as appropriate.
Compensation Determination Process
Compensation Committee Members. The Committee is responsible for establishing, overseeing and reviewing executive compensation policies and for approving, validating and benchmarking the compensation and benefits for named executive officers. The Committee is also responsible for determining the fees paid to our outside directors. The Committee included Mr. Volodymyr Cherevko and Mr. Michael Karg. Mr. Cherevko and Mr. Karg satisfied the independence requirements of NASDAQ.
Independent Compensation Consultant. The Committee engaged an independent compensation consultant, Compensia, to assist in its review of executive compensation for the Global Chief Executive Officer, Chief Financial Officer and General Counsel and Head of Global Functions (as well as outside director compensation). The consultant reviewed base salary, target annual bonus, target total cash compensation, long-term incentive annual grant value, and target total direct compensation, against peer company market data. The consultant assisted the Committee in setting the Global Chief Executive Officer’s compensation effective January 1, 2022 and for reviewing the compensation of all named executive officers for 2023.
19

TABLE OF CONTENTS

Although it is difficult to find a company exactly comparable to the Company, the consultant compared the compensation received by the Company's named executive officers with the levels of compensation received by similarly situated executives. For the Global Chief Executive Officer, Compensia conducted a review based on peer SEC filings from a 20-company peer group. For the Chief Financial Officer and General Counsel and Head of Global Functions, Compensia reviewed amongst similarly sized companies (e.g., less than 1B in market cap) using peer group aligned survey data.
Role of Management. During 2022, the Committee engaged in its annual review of executive compensation with the goal of ensuring the appropriate combination of fixed and variable compensation linked to individual and corporate performance. In the course of its review, the Committee considered (a) the advice and input of the Company’s Human Resources, Global Chief Executive Officer, General Counsel and Head of Global Functions and founder; (b) data prepared by management, including historical compensation and promotions; and (c) data prepared by the independent compensation consultant, as outlined above. Management and the consultant assisted the Committee to properly evaluate employee performance, establish business performance targets, goals and objectives and recommend salary and bonus levels. No executive officer participated in discussions regarding their own compensation.
Components of Executive Compensation
The Committee has structured an executive compensation program comprised mainly of base salary and equity, with a performance-based bonus provided to the Global Chief Executive Officer only. The mix of these components depends on the executive officer’s role, performance, tenure and experience.
Base Salary
The Committee considered three types of potential base salary modifications for the named executive officers in 2022: (1) “merit increases” based upon each named executive's individual performance; and/or (2) “market adjustments” based upon the salary range for similarly situated executives; and/or (3) “geographic adjustments” based on the physical location of the executive.
In determining merit increases, the Committee considered the specific responsibilities of the executive and the executive's overall performance and tenure with the Company. In addition, the Committee also considered an evaluation of each named executive officer provided by Human Resources in making the decision regarding merit increases.
The Committee determined any market adjustments based on the Committee's comparison of the executive's compensation with statistical information on average compensation for similarly situated executives provided by Compensia. The Committee also considered the key market factors impacting the Company and its overall performance. The Committee also reviewed the executive’s base salary as part of the overall package of compensation, meaning they considered granting additional equity to compensate for a lower base salary so that caseoverall compensation would be comparable to market.
As a global company, we have the tradingability to hire executives in various countries. As such, the base salary for such executives are reviewed to ensure alignment with the pay practices of the respective countries where they are physically located. As none of the executives moved locations in 2022, this factor was not as important as in previous years.
Note, Mr. Wayne Lee, who served as the Company’s Chief Financial Officer from September 2022 to March 2023, was a consultant and so was compensated at an hourly rate of $240, with minimum required hours per week of 24 hour and maximum of 40 hours, unless otherwise approved. Mr. Lee’s hourly rate was considered in the context of a reasonable base salary for a Chief Financial Officer to ensure the amount would be reasonable and align with the market.
Incentive Bonus Pay
Pursuant to the terms of Mr. Holger Bartel’s employment agreement, dated September 28, 2015, as amended effective January 1, 2022, Mr. Bartel was eligible to receive an annual performance bonus for 2022 at the beginning of 2023, in an amount of up to $150,000 tied to three (3) strategic goals to be determined by the Compensation Committee at the beginning of each year. For 2022, the Committee determined that the goals would be: (1) hiring, retaining and training a permanent General Manager, U.S.; (2) achieving greater than 5%
20

TABLE OF CONTENTS

EBITDA growth; and (3) completion of an operating budget for the year, with final delivery to the Board before the end of the first quarter of the year, including providing targets to all reports for their bonus agreements prior to the start of each quarter based on the completed operating budget. Mr. Bartel received a bonus of $100,000, having achieved goals (2) and (3). Three new strategic goals were set by the Compensation Committee for 2023.
None of the other named executive officers received a bonus opportunity in 2022.
Other Compensation-Related Matters
The Company grants stock options (which represent the right to purchase a specific number of shares of the Company’s Common Stock at a predetermined price, subject to vesting conditions) to certain executive staff, to align their incentives with the long-term interests of our stockholders, retain them for the long term, reward them for potential long-term contributions, and provide a total compensation opportunity commensurate with our performance.
As part of Mr. Holger Bartel’s compensation for 2022, the Compensation Committee granted Mr. Bartel stock options to purchase 600,000 shares of Common Stock with an exercise price of our common$8.14. The stock options vest bi-annually over two (2) years, beginning on June 30, 2022. The grant was subject to approval by the stockholders of the Company at the 2022 Annual Meeting and could decline.have been unwound if approval was not received. However, the shareholders approved the grant. The options expire in 2027. No additional options were granted to Mr. Bartel in 2022.
In 2022, Ms. Ciocca was not determined to be an “executive officer” by the Compensation Committee or the Board. Nevertheless, Ms. Ciocca’s compensation was reviewed by the Compensation Committee given Ms. Ciocca’s role on the Board to ensure impartiality. Ms. Ciocca did not receive an option grant in 2022.
In 2022, Ms. Lisa Su served as Chief Accounting Officer until September and then Mr. Wayne Lee served as Chief Financial Officer until March 31, 2023. Neither Ms. Su nor Mr. Lee received an option grant in 2022.
Perquisites and Additional Benefits. The Company seeks to maintain an open and inclusive culture in its facilities and operations among executives and other Company employees. Accordingly, the Company does not provide executives with reserved parking spaces or separate dining or other facilities, nor does the Company have programs for providing personal-benefit perquisites to executives, such as club dues or defraying the cost of personal entertainment. Named executive officers and employees may seek reimbursement for business related expenses in accordance with the Company's business expense reimbursement policy.
Employment Agreements.
The Company has entered into employment agreements with certain executive staff, some of which contain severance and change of control provisions. The terms of such employment agreements are described in more detail below in
Employment Agreements and Potential Payments Upon Termination or Change-in-Control. The Committee believes these agreements are appropriate for a number of reasons, including the following:

the agreements assist in attracting and retaining executives as we compete for talented employees in a marketplace where such agreements are commonly offered;
the change in control provisions require terminated executives to execute a release in order to receive severance benefits; and
15the change in control and severance provisions help retain key personnel during rumored or actual acquisitions or similar corporate changes.
21


CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION


TABLE OF CONTENTS

Summary Compensation Table
This proxy statement and the documents to which we refer you in this proxy statement contain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties, and assumptions that are difficult to predict. These forward-looking statements includeThe following summary compensation table sets forth information concerning the Company’s plans, objectives, goals, strategies, future events, future revenues, performance, capital expenditures, financing needscompensation of our Global Chief Executive Officer, former Chief Accounting Officer, and former Chief Financial Officer during the fiscal years ended December 31, 2022 and 2021.
Name and Principal Position
Fiscal
Year
Salary
($)
Bonus
($)(a)
Option
Awards
($)(b)
Non-Equity
Incentive Plan
Compensation
($)(c)
All Other
Compensation
($)(d)
Total
($)
Holger Bartel(1)
Global Chief
Executive Officer
2022
450,000
100,000
1,730,400
2,280,400
2021
232,000
232,000
 
 
 
 
 
 
 
 
Christina Sindoni Ciocca(2)
General Counsel and
Head of Global Functions
2022
335,000
1,500
336,500
2021
 
 
 
 
 
 
 
 
Lisa Su(3)
Former Chief Accounting Officer
2022
220,055
1,500
221,555
2021
300,000
50,000
1,500
351,500
 
 
 
 
 
 
 
 
Wayne Lee(4)
Former Chief Financial Officer
2022
152,457
152,457
2021
 
 
 
 
 
 
 
 
Michele Huiban(5)
Former Chief Financial Officer
2022
2021
99,911
28,546
128,457
(1)
Mr. Holger Bartel's annual salary was increased to $450,000 effective January 1, 2022, for his role as Global Chief Executive Officer.
(2)
Ms. Ciocca was appointed as an executive officer in March of 2023. Ms. Ciocca’s current salary is equal to $350,000 per annum. $335,000 represents annual salary cost based on one quarter at prior salary level.
(3)
Ms. Su was appointed as the Company's Chief Accounting Officer in July 2019. Effective July 1, 2021, Ms. Su’s base salary was increased from $280,000 to $320,000, in consideration of termination of Ms. Su’s outstanding bonus plan and move out-of-state. Ms. Su left the Company on September 9, 2022. $220,055 represents pro-rated annual salary for 2022 through the date of termination.
(4)
Mr. Wayne Lee provided consulting services to the Company as Chief Financial Officer from September 2022 to March 2023, at an hourly rate of $240. $152,457 represents the aggregate fees charged by Mr. Lee through December 31, 2022. Mr. Lee left the Company on March 31, 2023.
(5)
Ms. Huiban was with the Company for 3 months (April through June) of 2021. $99,910 represents annual salary cost of €350,000, converted to USD and based on 3 months of employment. Ms. Huiban was eligible to receive a bonus each quarter equal to €25,000 or $28,546. Because Ms. Huiban left the Company after Q1 of 2021, she earned only one bonus.
(a)
Amounts consist of bonuses earned per the terms of employment agreements or bonus plans and/or at the discretion of the Board of Directors or the Compensation Committee, as applicable.
(b)
The values reported reflect the aggregate grant date fair value of grants of stock options to each of the listed officers in the years shown. The grant date fair value of stock options is calculated using the Black-Scholes option pricing model. For a more detailed discussion on the valuation model and assumptions used to calculate the fair value of our options, refer to Note 10 to the consolidated financial statements contained in our 2022 Annual Report on Form 10-K filed on March 31, 2023.
(c)
The amounts reflected in this column reflect any performance-based cash awards paid to the named executives pursuant to certain employment agreements, as discussed in the “Executive Compensation” section above. There were no such amounts paid during 2022 and 2021.
(d)
The amounts in this column reflect all other compensation paid to the named executives including $1,500 Company matching 401(k) plan contribution and other miscellaneous payments made to eligible employees.
22

TABLE OF CONTENTS

Grants of Plan-Based Awards in 2022
The following table sets forth certain information with respect to non-equity incentive plan awards granted to each of our named executive officers during the fiscal year ended December 31, 2022.
 
Estimated Possible Payouts
Under Non-Equity
Incentive Plan Awards
Name(1)
Threshold
($)
Target
($)
Maximum
($)
Holger Bartel
150,000
150,000
150,000
Christina Sindoni Ciocca
Lisa Su
Wayne Lee
(1)
Amount represents the potential annual performance bonus payments under the terms of the applicable employment agreement or bonus agreement. The business measurements and performance goals for determining the performance bonus payout are described in the section entitled “Executive Compensation”.
Outstanding Equity Awards as of December 31, 2022
The following table sets forth certain information with respect to outstanding equity awards as of December 31, 2022.
 
Option Awards
Name
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
Option
Exercise
Price
($)
Option
Expiration Date
Holger Bartel(1)
300,000
300,000
8.14
March 3, 2027
Christina Sindoni Ciocca(2)
25,000
50,000
3.49
March 30, 2025
Lisa Su(3)
3.49
March 30, 2025
(1)
600,000 options were granted to Mr. Holger Bartel in 2022. The options are exercisable in semi-annual increments of 25% from June 30, 2022 through December 31, 2023.
(2)
Although Ms. Ciocca was not designated as an executive officer in 2022, Ms. Ciocca’s option grant outstanding as of December 31, 2022 is included for completeness. Ms. Ciocca was granted 100,000 options in 2020. The options are exercisable in annual increments of 25% from March 30, 2021 through March 30, 2024. Ms. Ciocca exercised the first tranche of 25,000 options in 2021. Ms. Ciocca did not exercise the second tranche in 2022, which is now vested and exercisable. There are 50,000 options remaining unvested.
(3)
100,000 options were granted to Ms. Lisa Su in 2020. However, Ms. Su left the Company in September 2022, meaning Ms. Su’s outstanding option agreement was terminated (50,000 remained unvested and unexercised and were therefore forfeited).
Option Exercises and Stock Vested
In March 2021, the first 25% of Ms. Su’s options vested and Ms. Su exercised all 25,000 options via cashless exercise in April. Ms. Su’s next tranche of 25,000 options vested in March 2022 and Ms. Su exercised all 25,000 options via cashless exercise in October. Ms. Su left the Company in September 2022 and upon Ms. Su’s departure, her outstanding option agreement terminated (with 50,000 options remaining unvested).
In March 2021, the first 25% of Ms. Ciocca’s options granted in 2020 vested and Ms. Ciocca exercised all 25,000 options via cashless exercise in April 2021. The second tranche of 25% of the options granted in 2020 to Ms. Ciocca has not yet exercised. Stemming from the grant in 2020, Ms. Ciocca has 50,000 remaining unvested options that is not historical information. When usedwill vest over the next two years.
Mr. Holger Bartel exercised 540,000 options in this proxy statementApril 2022. Such options were the final options remaining under his previous option agreements (granted in 2015, 2017 and the documents to which we refer you in this proxy statement, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “may,” “should,” “seeks,”2019).
23

TABLE OF CONTENTS

Employment Agreements and variations of such wordsPotential Payments Upon Termination or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, without limitation, the Company’s examination of historical operating trends, are based upon the Company’s current expectations and various assumptions. Change-in-Control
The Company believes therehas employment or consulting agreements with its named executive officers. The employment or consulting agreements in place as of December 31, 2022 with the Company's named executive officers are described below.
Mr. Holger Bartel entered into an employment agreement with the Company on September 28, 2015. The Company may terminate the employment agreement, with or without cause, upon written notice to Mr. Holger Bartel. However, if Mr. Holger Bartel's employment is a reasonable basis for its expectations and assumptions, but there can be no assuranceterminated at any time without cause, Mr. Holger Bartel's remaining stock options will immediately vest in full on the date of termination. Mr. Holger Bartel agreed that the Company will realize its expectationsown any discoveries and work product (as defined in the agreement) made during the term of his employment and to assign all of his interest in any and all such discoveries and work product to the Company.
Ms. Ciocca entered into an employment agreement with the Company on April 2, 2018. Pursuant to the terms of the agreement, Ms. Ciocca is an at-will employee meaning the Company or Ms. Ciocca could terminate the agreement at any time, with or without cause, upon two (2) weeks’ prior notice to the other party.
Ms. Ciocca agreed that the Company will own any discoveries and work product (as defined in the agreement) made during the term of her employment and to assign all of her interest in any and all such discoveries and work product to the Company. Furthermore, Ms. Ciocca agreed to not, directly or indirectly, solicit the Company's customers or employees during the term of her employment and for a period of one (1) year thereafter.
Mr. Lee entered into a consulting agreement with the Company on August 9, 2022 through Agnitio Partners LLC for six (6) months of Chief Financial Officer services through March 1, 2023. The consulting agreement was extended by mutual agreement for an additional month. Mr. Lee’s engagement could be terminated at any time by the Company with seven (7) days’ written notice and by Mr. Lee with 30 days’ written notice.
Mr. Lee agreed that the Company will own any work product (as defined in the agreement) made during the term of his engagement and to assign all of his interest in any and all such work product to the Company.
24

TABLE OF CONTENTS

Pay Versus Performance
As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and our other named executive officers (“Non-PEO NEOs”), and company performance for the fiscal years listed below. Our Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown. For further information concerning our pay-for-performance philosophy and how we structure our executive compensation to drive and reward performance, refer to the section entitled “Executive Compensation”. The amounts shown for “Compensation Actually Paid” have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by our named executive officers for any of the periods listed. These amounts reflect Summary Compensation Table total compensation with certain adjustments as described in the following table and footnotes.
(1)
(2)
(3)
(4)
(5)
(6)
(7)
Year
Summary
Compensation
Table Total
for PEO
($)
Compensation
Actually Paid
to PEO
($)
Average
Summary
Compensation
Table Total
for Non-PEO
Named
Executive
Officers
($)
Average
Compensation
Actually Paid
to Non-PEO
Named
Executive
Officers
($)
Value of
Initial Fixed
$100
Investment
Based on
Total
Shareholder
Return
($)
Net
Income
($)
2022
2,280,400
1,565,200
236,837
19,071
$47.14
6,634,000
2021
232,000
1,464,860
239,934
297,119
$99.79
911,000
(1)
Holger Bartel served as our PEO for the entirety of fiscal years 2021 and 2022. Our Non-PEO NEOs for 2021 were Lisa Su and Michele Huiban. Our Non-PEO NEOs for 2022 were Christina Sindoni Ciocca, Lisa Su and Wayne Lee.
(2)
Amounts reported in this column represent the total compensation reported in the Summary Compensation Table for the applicable year for our PEO
(3)
Amounts reported in this column represent the compensation actually paid to the PEO, based on his total compensation reported in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the table below:
PEO
 
2021
($)
2022
($)
Summary Compensation Table – Total Compensation
(a)
232,000
2,280,400
Minus Grant Date Fair Value of Stock Awards and Option Awards Granted in Fiscal Year
(b)
0
1,730,400
Plus Fair Value at Fiscal Year End of Outstanding and Unvested Stock Awards and Option Awards Granted in Fiscal Year
(c)
0
405,938
Plus Change in Fair Value of Outstanding and Unvested Stock Awards and Option Awards Granted in Prior Fiscal Year
(d)
0
0
Plus Fair Value at Vesting of Stock Awards and Option Awards Granted in Fiscal Year That Vested During Fiscal Year
(e)
0
609,262
Plus Change in Fair Value as of Vesting Date of Stock Awards and Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year
(f)
1,232,860
0
Minus Fair Value as of Prior Fiscal Year End of Stock Awards and Option Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year
(g)
0
0
equals
 
 
 
Compensation Actually Paid
 
1,464,860
1,565,200
(a)
Represents Total Compensation reported in the Summary Compensation Table for the indicated fiscal year.
(b)
Represents the aggregate grant date fair value of the stock awards and option awards granted to the PEO during the indicated fiscal year, computed in accordance with FASB ASC 718.
(c)
Represents the aggregate fair value as of the indicated fiscal year-end of the PEO’s outstanding and unvested stock awards and option awards granted during such fiscal year, computed in accordance with FASB ASC 718.
(d)
Represents the aggregate change in fair value during the indicated fiscal year of the outstanding and unvested stock awards and option awards held by the PEO as of the last day of the indicated fiscal year, computed in accordance with FASB ASC 718.
(e)
Represents the aggregate fair value at vesting of the stock awards and option awards that were granted to the PEO and vested during the indicated fiscal year, computed in accordance with FASB ASC 718.
(f)
Represents the aggregate change in fair value, measured from the prior fiscal year-end to the vesting date, of each stock award and option award held by the PEO that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with FASB ASC 718.
25

TABLE OF CONTENTS

(g)
Represents the aggregate fair value as of the last day of the prior fiscal year of the PEO's stock awards and option awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB ASC 718.
There were no dividends or other earnings paid on the stock awards or option awards in the covered fiscal years.
(4)
Amounts reported in this column represent the average of the total compensation reported in the Summary Compensation Table for the applicable year for our Non-PEO NEOs.
(5)
Amounts reported in this column represent the compensation actually paid to our Non-PEO NEOs in the indicated fiscal year, based on the average total compensation for such Non-PEO NEOs reported in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the table below:
NEO Average
 
2021
($)
2022
($)
Summary Compensation Table – Total Compensation
(a)
239,934
177,628
Minus Grant Date Fair Value of Stock Awards and Option Awards Granted in Fiscal Year
(b)
0
0
Plus Fair Value at Fiscal Year End of Outstanding and Unvested Stock Awards and Option Awards Granted in Fiscal Year
(c)
0
0
Plus Change in Fair Value of Outstanding and Unvested Stock Awards and Option Awards Granted in Prior Fiscal Year
(d)
(12,261)
(122,531)
Plus Fair Value at Vesting of Stock Awards and Option Awards Granted in Fiscal Year That Vested During Fiscal Year
(e)
0
0
Plus Change in Fair Value as of Vesting Date of Stock Awards and Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year
(f)
69,446
(36,026)
Minus Fair Value as of Prior Fiscal Year End of Stock Awards and Option Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year
(g)
0
0
equals
 
 
 
Compensation Actually Paid
 
297,119
19,071
(a)
See footnote 1 for the NEOs included in the average for each indicated fiscal year. Represents the average Total Compensation as reported in the Summary Compensation Table for the reported NEOs in the indicated fiscal year.
(b)
Represents the aggregate grant date fair value of the stock awards and option awards granted to the Non-PEO NEOs during the indicated fiscal year, computed in accordance with FASB ASC 718.
(c)
Represents the aggregate fair value as of the indicated fiscal year-end of the Non-PEO NEO’s outstanding and unvested stock awards and option awards granted during such fiscal year, computed in accordance with FASB ASC 718.
(d)
Represents the aggregate change in fair value during the indicated fiscal year of the outstanding and unvested stock awards and option awards held by the Non-PEO NEO as of the last day of the indicated fiscal year, computed in accordance with FASB ASC 718.
(e)
Represents the aggregate fair value at vesting of the stock awards and option awards that were granted to the Non-PEO NEO and vested during the indicated fiscal year, computed in accordance with FASB ASC 718.
(f)
Represents the aggregate change in fair value, measured from the prior fiscal year-end to the vesting date, of each stock award and option award held by the Non-PEO NEO that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with FASB ASC 718.
(g)
Represents the aggregate fair value as of the last day of the prior fiscal year of the Non-PEO NEO's stock awards and option awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB ASC 718.
There were no dividends or other earnings paid on the stock awards or option awards in the covered fiscal years.
(6)
Assumes $100 invested as of December 31, 2020 through the end of the applicable year.
(7)
The dollar amounts represent the amount of net income (loss) attributable to Travelzoo reflected in our audited financial statements for the applicable fiscal year.
26

TABLE OF CONTENTS

Relationship Between Pay and Performance
Compensation Actually Paid, as required under SEC rules, reflects adjusted values to unvested and vested equity awards during the years shown in the table based on year-end stock prices and various accounting valuation assumptions, but does not reflect actual amounts paid out for those awards. Compensation Actually Paid generally fluctuates due to stock price performance. We believe the “Compensation Actually Paid” in each of the years reported herein and over the two-year cumulative period are reflective of the Compensation Committee’s emphasis on “pay-for-performance” as the “Compensation Actually Paid” fluctuated year-over-year, primarily due to the result of our stock performance. Below are graphs showing the relationship of Compensation Actually Paid to our Global CEO and Non-PEO NEOs for 2021 and 2022 to (1) the Company’s assumptions will prove correct.cumulative TSR and (2) the Company’s net income:

Relationship Between Compensation Actually Paid and TSR
In addition
Relationship Between Compensation and Net Income

27

TABLE OF CONTENTS

Forward-Looking Statements
Statements that do not relate strictly to historical or current facts are forward-looking and usually identified by the use of words such as “anticipate,” “estimate,” “approximate,” “expect,” “intend,” “plan,” “believe” and other factors and matterswords of similar meaning in connection with any discussion of future operating or financial matters. Without limiting the generality of the foregoing, forward-looking statements contained or incorporated in this document, we believereport include the followingmatters discussed regarding the expectation of compensation plans, strategies, objectives, and growth and anticipated financial and operational performance of the Company and its subsidiaries. A variety of factors could cause the Company's actual results to differ materially from those discussedthe anticipated results or other expectations expressed in the Company's forward-looking statements:

the occurrence of any event, change, or other circumstances that could give rise to the termination of the Stock Purchase Agreement;
the inability to consummate the Issuancestatements. The risks and uncertainties that may affect the operations, performance and the Merger due to the failure to obtain stockholder approval of the Issuance or failure to satisfy any other conditions to the consummation of the Issuance;
business uncertainty and contractual restrictions during the pendency of the Issuance;
adverse outcomes of pending or threatened litigation or governmental investigations;
the failure of the Issuance to be consummated for any other reason;
the amount of the costs, fees, expenses and charges related to the Issuance;
diversion of management’s attention from ongoing business concerns;
the effect of the announcement of the Issuance on the Company’s business and customer relationships, operating results and business generally, including the ability to retain key employees;
the risks that the Issuance or the Merger disrupts current plans and operations;
the possible adverse effect on our business and the price of our common stock if the Issuance is not consummated in a timely fashion or at all;
risks that we may be unable to successfully integrate MTE’s business and personnel with our own;
Risks that the expected benefits of the Issuance may not be realized, including utilization of the NOLs; and
other risks and uncertainties applicable to our business set forth in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2021. See section “Additional Information” below.

Many of the factors that will determine our future results are beyond our ability to control or predict. We cannot guarantee any future results, levels of activity, performance, or achievements. In light of the significant uncertainties inherent in theCompany's business and forward-looking statements readers shouldinclude, but are not place undue reliance on forward-looking statements, which speaklimited to, those set forth herein. Any forward-looking statement speaks only as of the date on which the statements weresuch statement is made and it should not be assumed that the statements remain accurate as of any future date.

You should carefully consider the cautionary statements contained or referred to in this section in connection with any subsequent forward-looking statements that may be issued by us or persons acting on our behalf.



16


APPROVAL OF THE ISSUANCE PROPOSAL

(Proposal No. 1)

THE ISSUANCE

Background of the Transaction and Overview

In line with the strategic objective to increase its membership base through mergers and acquisitions (M&A), Travelzoo has an M&A desk constituted of members of Travelzoo’s management and board of directors with M&A and industry experience. This M&A desk has been consistently meeting since approximately September 2019. Since its inception, the M&A desk has evaluated hundreds of potential acquisition targets, undertaken in-depth due diligence inquiries into and entered negotiations with at least seven potential targets, and successfully closed more than four transactions, including the acquisition of a majority stake in JFC Travel Group Co. (a paid subscription membership company), the investment into and later sale of such investment in weekengo GmbH (a weekend travel company) and the acquisition of assets in the United States and a branch in Spain from a competing membership-based travel company.

In line with the strategic objective to expand its product offerings, including for times when physical travel is limited or impossible due to extraordinary events such as, for example, another global pandemic, Travelzoo management started as early as the second half of 2021 to assess opportunities for Travelzoo related to Metaverse travel. Beginning in January 2022, Travelzoo hired an executive focused on building a paid subscription membership. While the original plan was for this executive to focus on a Travelzoo-based paid subscription membership, after conducting research into the fast-growing market of Metaverse travel and experiences, it was decided that the Travelzoo paid subscription membership would be focused on the Metaverse specifically. In a presentation to the Audit Committee at the beginning of March 2022, it was noted that in 2021 the US Metaverse market was approximately $58.5 billion, which accounted for 41% of the global market share. This was discussed in further detail with the board of directors of Travelzoo during the Q1 2022 board meeting, where the board supported the plan of gathering additional data and building a strategy to move into this space.

As Travelzoo began building out its strategy for a paid subscription membership for Metaverse travel experiences, it became obvious that sourcing high-quality, unique, exclusive Metaverse experiences, and more specifically sourcing the creators who had made or could make such experiences, would be critical to the success of Travelzoo META and that Travelzoo did not have the internal resources with the necessary connections or skills to manage this aspect of the business. As discussed in further detail below, MTE had already begun building a global team to focus on sourcing Metaverse experiences specifically. As such, the Company entered into a service agreement with MTE on March 1, 2022, whereby MTE agreed to exclusively source Metaverse travel experiences and creators for the Company, in exchange for a monthly fee of $25,000 and a commission of 25% of all subscription revenues generated by Travelzoo META (the “Service Agreement”).

Based on the insights and experiences gained over the period since the entry into the Service Agreement, in particular in relation to the uncertainty of expected subscriber numbers as well as expected margins, Travelzoo’s management believes that the acquisition of MTE will likely be economically more attractive for the Company than continuing to pay the monthly fee and any future (and potentially very high) commission share under the Service Agreement.

Additionally, as the Company continues its recovery from the pandemic, mainly due to increased liabilities for vouchers that are expiring in the next few years, the Company is in a negative net working capital position. Although management of the Company believes that the Company has significant capital to meet its ongoing obligations, management also expects cash levels to be at their lowest in the next few quarters, with gradual increases over the course of next year.

Therefore, in combination with the advantages presented by the Merger, the Issuance is also attractive to the Company because it would provide some liquidity to the Company during a time when the Company has negative net working capital and lower cash levels and because a capital raise by way of the proposed private placement appears superior to alternative options. Specifically, one alternative option of obtaining a debt facility of some kind (most likely a revolving credit facility) would, as confirmed by Travelzoo’s banking partner, come with considerable restrictions in the form of covenants and pledges of security interests over Travelzoo’s most valuable assets (cash, intellectual property, subsidiaries, etc.), neither of which are present with the Issuance.

The other alternative option of raising equity from existing shareholders other than Azzurro or new investors presents the disadvantage that such shareholders or investors, when invited to acquire a considerable stake in a private placement, will likely request a non-negligible discount on the share price. A public offering, in turn, would be more costly than a private placement because of added legal and administrative requirements. Such alternative equity issuance would also not present the added advantages of the Merger relating to MTE (elimination of payment obligations under Service Agreement; direct control over Metaverse experience scouting; utilization of MTE’s NOLs), nor would it further management’s strategic goal to ensure long term stability and continuity in Travelzoo’s stockholder base on the basis of a robust corporate governance and compliance framework designed for a company with a controlling shareholder.

17


For all of these reasons, on November 25, 2022, the Company entered into the Stock Purchase Agreement with Azzurro providing for the Issuance, in exchange for (a) $10 million, payable, at the election of Azzurro, in cash or as a combination of no less than $2 million in cash and up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of MTE.

Background of Metaverse Travel Experiences, Inc. (“MTE”), formerly known as Azzurro Brands, Inc. (“AB”)

In the first few years after incorporation, MTE had three stores located in the states of New York and Nevada. MTE licensed from an unrelated third party the trademark “Devi Kroell” in the field of fashion, accessories, fragrances, cosmetics, etc. MTE utilized this trademark for several years and then in 2014, sub-licensed it to Devi Kroell S.R.L., an affiliated entity. MTE’s Nevada location was closed in 2013 and the New York City location on Madison Avenue was closed in 2017. Until recently, MTE operated as last remaining store a seasonal store in East Hampton, New York under the name Devi Kroell.

Since 2017, MTE has considered various investment opportunities to pivot its business model. As it had historically been involved in various licensing arrangements, in March of 2021, MTE purchased an email database from a significant competitor of the Company (the “Database”), which it then licensed to Travelzoo for its exclusive use. Travelzoo preferred to license the Database initially, rather than purchase it outright, to minimize the cash needed to be expended by Travelzoo and to mitigate the risk of data privacy issues during the transition phase of moving over the email addresses.

On January 3, 2022, MTE legally changed its name from “Azzurro Brands, Inc.” to “Metaverse Travel Experiences, Inc.” and hired a team of professionals who began building worldwide relationships with creators and providers of high quality Metaverse experiences with the goal of brokering contacts between such creators/experience providers and businesses planning to market Metaverse experiences to consumers. On March 1, 2022, MTE entered into the exclusive Service Agreement with Travelzoo to scout for Metaverse experiences in support of Travelzoo’s new strategic business opportunity of building a premium subscription membership for the Metaverse. In that same month, MTE sold the membership database to Travelzoo (after Travelzoo had successfully transitioned the email addresses and realized value of more than $1M in purchases from the members in the database) to consolidate its business operations and focus on Metaverse experience scouting.

MTE is wholly owned by Azzurro, whose sole shareholder is The Ralph Bartel 2005 Trust, whose sole beneficiary is Ralph Bartel, the Chairman of the Board of the Company.

Potential Transaction with Azzurro Brands, Inc. (“AB”) (March 2020 through December 2021)

As part of its ongoing growth by acquisition strategy, Travelzoo and AB approached each other several times since early 2020 to discuss a possible acquisition of AB with the goal of expanding Travelzoo’s membership base and product offerings.

In March of 2020, Travelzoo discussed with Grant Thornton the possibility of Travelzoo acquiring AB to use it as vehicle for the U.S. expansion of Travelzoo’s then-newly acquired 60% subsidiary JFC Travel Group Co. Before a possible transaction was concluded, the COVID-19 pandemic struck and the project was de-prioritized by Travelzoo.

In November of 2020, Travelzoo re-engaged with Grant Thornton to conduct a feasibility analysis on the acquisition of AB. Grant Thornton presented the preliminary results of its analysis on December 17, 2020, discussing generally the two options available for the transaction – a taxable purchase or a tax-free reorganization. On December 23, 2020, Grant Thornton provided structure charts outlining these two options. After internal discussions at the Company, including members of the Company’s board who serve as independent directors, the Company advised Grant Thornton to look deeper into the second option of a tax-free reorganization. Grant Thornton provided the results of the work, which was an in-depth feasibility analysis of the tax-free reorganization, on February 15, 2021, advising that for a tax-free reorganization to be in compliance with tax requirements, the Azzurro Group, which is comprised of Azzurro, its sole shareholder. The Ralph Bartel 2005 Trust and Ralph Bartel, as the sole beneficiary of the Trust, would need to have greater than 50% ownership of Travelzoo at the closing of the transaction.

After communications from the Company that an acquisition of AB would be feasible, and even beneficial, to the Company from a tax perspective, Azzurro Capital then submitted a proposal to the board of directors of Travelzoo for the acquisition of AB on March 23, 2021, which offered to sell AB to the Company in exchange for 1,800,000 shares of the Company, which given the share price of around $15.25, implied total consideration of approximately $27,450,000.

On that same day, the Board via a unanimous written consent, appointed a Special Committee, comprised solely of independent and disinterested directors, to determine whether a potential transaction would be in the best interests of the Company and its stockholders, other than Azzurro and its affiliates, and review, evaluate and negotiate the terms of any definitive agreements, as well as appoint independent legal, financial, and other advisors, in their discretion.

On March 25, 2021, the Company entered into a confidentiality agreement with AB to begin conducting additional due diligence on AB specifically.

18


On April 9, 2021, upon the request of the Special Committee, management of the Company began to prepare internal forecasts for US taxable income for 2021, 2022 and 2023.

On April 15, 2021, the Special Committee appointed Ballard Spahr LLP to act as its independent legal advisor. On April 21, 2021, the Special Committee and its independent legal advisor held their first meeting. The independent legal advisor advised the Special Committee members of their fiduciary duties in connection with a potential transaction and discussed certain preliminary issues relating to evaluating a potential transaction. The Special Committee discussed the structure and timing for the proposed transaction. On April 23, 2021, the Special Committee held another meeting with counsel in order to receive an update regarding due diligence.During that meeting, the Special Committee and the representatives of Ballard Spahr also reviewed the independence and disinterestedness determinations for the members of the Special Committee.

On April 28, 2021, the Special Committee met via videoconference with Grant Thornton to discuss the proposed transaction and their analysis of the net operating losses of AB. In order to fully understand the value of the net operating losses to the Company, the Company’s Chief Financial Officer began working on projections for the Company’s US taxable income over the next 10 years. Once completed, the Company worked with Grant Thornton to update the NOL utilization estimates.

Following the meeting, the Company requested that Grant Thornton prepare technical documentation and a supporting memo for the potential transaction and utilization of the NOLs. On May 8, 2021, management of the Company met with Grant Thornton to discuss questions relating to Grant Thornton’s analysis and the tax treatment of the transaction as well as their evaluation of the quality of the NOLs. Following the meeting, management decided to engage Grant Thornton to conduct detailed due diligence into the quality of the NOLs.

On May 20, 2021, the Company met with its independent auditors, RSM US LLP, to discuss their questions and any accounting matters to be considered for the potential transaction.

On May 26, 2021, the Special Committee held a meeting, via video conference, with management and its independent legal advisor to discuss the potential transaction. Management proposed a potential restructure, which would incorporate the potential transaction, business justifications for the restructure, proposed valuation of AB from management’s perspective (subject to review by the Special Committee’s independent financial advisor), analysis of the consideration and accounting considerations. As part of the proposed valuation of AB, management also discussed a 10-year US taxable income forecast, with 3 scenarios, prepared by the Company’s Chief Financial Officer and Business Controlling Director.

On May 27, 2021, Grant Thornton met with Azzurro to discuss certain outstanding due diligence questions and send a follow-up list of questions and diligence requests following the call.

On June 1, 2021, Grant Thornton provided an excerpt of the technical memo for review by management in terms of factual accuracy.

On June 4, 2021, the Company’s Chief Financial Officer shared additional information with the Special Committee, specifically some explanation regarding the underlying assumptions, for the previously presented U.S. taxable income forecast.

On June 6, 2021, Azzurro and Azzurro’s tax advisor met with Grant Thornton and the Company’s General Counsel to discuss the resolution of the outstanding shareholder loans of AB, an issue that came up during due diligence.

On June 9, 2021, RSM provided some initial feedback to Grant Thornton regarding the technical memo. The feedback centered on the discussion in the memo concerning the business purpose of the transaction in the context of Code section 269, among other additional questions.

On the same day, Grant Thornton provided the initial findings of their due diligence of AB and the NOLs, which were reviewed by the Company and shared with the Special Committee. The diligence report included an NOL schedule which estimated the total NOLs of AB to be $63,518,000 and stated that Grant Thornton did not anticipate material limitations, if any, related to the future use of the NOLs. The diligence report did not contain any material red flags.

On June 25, 2021, Grant Thornton provided the full initial draft of the technical memo to the Company. Management reviewed the memo to ensure its factual accuracy and shared the memo with the Special Committee. The memo analyzed certain tax impacts to the Company from the proposed transaction, including the potential benefits to be received by the Company from the NOLs of AB.



19


On July 2, 2021, the Special Committee, along with its independent legal advisor, met with management, the Company’s auditors and Grant Thornton to review Grant Thornton’s technical memo draft, as well as the status of the potential transaction. The Special Committee focused particularly on the business purpose of the transaction, as they wanted to ensure that the various business justifications provided by management for acquiring AB aligned with the strategy of the Company and the requirements of the Code and would be in the best interests of the stockholders. Questions were also raised concerning some of the outstanding assets still contained within AB, including assets relating to the historic business of AB. The Special Committee also discussed with Grant Thornton the standard of review included in the technical memo (i.e., the “more likely than not” standard).The Special Committee also directed its independent legal adviser to contact a potential financial advisor to independently advise the Special Committee as to the fairness of a potential transaction.

At this point, although regular status updates had been provided to Azzurro, no formal negotiations had commenced and the Special Committee still had not determined whether they wanted to officially proceed with the potential transaction. The Special Committee had not yet engaged an independent financial advisor to limit expenses until they were certain that the transaction should continue to be considered.

Following the meeting, the Special Committee requested management to run additional analyses regarding whether any outstanding options held by Ralph Bartel, as an individual, should be included in the potential transaction. The Special Committee also requested an updated U.S. taxable income forecast and cash forecast, as some time had passed since the last analysis.

On July 12, 2021, management provided an updated copy of the technical memo to the Company’s auditors, RSM, for further review, including by their tax specialist. In furtherance of feedback from the Special Committee, management requested to understand the tax and accounting treatment of the transaction, to ensure no impact to the utilization of the NOLs by the Company, and asked RSM to check for any concerns relating to the potential insolvency of AB as part of the potential transaction. RSM responded to the Special Committee’s questions on July 22, 2021, explaining that the potential transaction, if consummated, would be considered a material transaction and therefore subject to various audit procedures and assessments on the Company’s disclosure.

On July 20, 2021, the Special Committee held a meeting with its independent legal adviser relating to the transaction.The purpose of the meeting was to discuss the status of the proposed transaction and the potential engagement of Stout Risius Ross LLC, or Stout, as an independent financial advisor to the Special Committee in connection with the transaction.The Special Committee considered Stout’s independence and the prior work performed by Stout for the independent directors of the board.Following discussion, the Special Committee directed the representatives of Ballard Spahr to move forward with engaging Stout as the Special Committee’s independent financial advisor, subject to negotiation of an acceptable engagement letter. The Special Committee also discussed the status of the proposed transaction and due diligence.

On August 2, 2021, management, the Special Committee and its independent legal advisor, the Company’s auditors and Grant Thornton receive an update on Grant Thornton’s analysis of the tax and accounting treatment for the potential transactions as well as Grant Thornton’s diligence of AB.

On August 5, 2021, the independent legal advisor to the Special Committee, management and Grant Thornton met to discuss additional questions from the Special Committee relating to the transaction and diligence of AB. Following the meeting, Grant Thornton agreed to update the technical memo to include state tax considerations for the potential transaction and consequences on the potential transaction should the store be sold and the transaction no longer qualifying for reorganization treatment. Grant Thornton also agreed to consider the effects on the transaction for a valuation where the majority of the value is the NOLs.

On August 13, 2021, the Special Committee and its independent legal and financial advisors as well as representatives of Stout met with management to receive updates from management on their diligence of AB on and the possible valuation for MTE’s assets. The Special Committee also received input from management regarding potential terms for the proposed transaction.The Special Committee then discussed such proposed terms and potential next steps with its independent legal adviser.

In mid-August 2021, the representatives of Ballard Spahr, the Special Committee’s independent legal advisor, proceeded to negotiate an engagement letter with the representatives of Stout to potentially engage them as independent financial advisors to the Special Committee for the potential transaction.

On August 19, 2021, Grant Thornton provided an updated draft of the technical memo to the Company. The updated technical memorandum detailed certain assets of AB that would not be required to be included in the transaction, since such asset was only relevant for determining whether or not the transaction would be a tax-free reorganization for Azzurro. Grant Thornton also confirmed that there may be sufficient continuity of AB’s business in order to constitute a tax-free reorganization in light of the use of the membership database before and after the contemplated transaction.


20


On September 10, 2021, the Special Committee engaged Stout as their independent financial advisor to conduct an analysis regarding the fairness of the transaction from a financial standpoint to the Company and its stockholders.

On September 24, 2021, Grant Thornton provided a further updated technical memo.

On September 28, 2021, the Special Committee, along with its legal and financial advisor, met with management and Grant Thornton to discuss certain due diligence questions raised by Stout as it began to conduct its analysis.

On September 29, 2021, Stout provided the Special Committee with an initial draft of its analysis. The analysis reviewed the Company’s 1-year and 5-year stock performance and trading statistics and volume-weighted average prices of the company’s shares of common stock for 5, 10, 15 and 20 trading days. The analysis also reviewed management’s U.S. taxable income forecast and Grant Thornton’s NOL utilization analysis, along with an analysis of the asset of the membership database, to provide a preliminary estimate of the implied value of AB. For clarity, Grant Thornton did not opine on the valuation of AB, but only the utilization of the NOLs, which management reviewed along with its U.S. taxable income forecast and submitted to Stout. Stout also conducted an analysis of the proposed consideration to be included in the transaction. The Special Committee discussed with Stout whether a discount should be applied to restricted shares that would be issued in connection with the proposed transaction.

On October 11, 2021, management, representatives of Azzurro and the Special Committee’s independent legal advisor met to discuss the status of the potential transaction. Based on the conversation, there appeared to be a gap in the valuation of AB when comparing Stout’s analysis and the proposal provided by Azzurro.

Management had further discussions with Stout and Grant Thornton regarding the estimated discount rate and effective tax rate utilized in Stout and Grant Thornton’s analyses. The Special Committee directed its advisors to communicate to Azzurro that its view on AB’s valuation had not changed, and that, as currently contemplated for the proposed transaction, Azzurro would need to provide additional value or assets, including cash, before the transaction could proceed further.

On October 19, 2021, Azzurro withdraw its proposal. Management continued its review of potential options for the transaction, with various questions exchanged over email with its tax advisor, Grant Thornton.

On November 12, 2021, management contacted the Special Committee and its independent legal advisor to discuss a potential alternative structure for an acquisition of AB.

On November 16, 2021, management met with its auditors to discuss again Grant Thornton’s technical memo. On November 17, 2021, RSM’s tax specialist provided feedback regarding the background information that should be included in the technical memo. An updated draft of the memo was provided back to RSM on November 19, 2021. After additional review by management and discussion with Grant Thornton, a further updated draft of the technical memo was provided to Grant Thornton on November 29, 2021. On the same day, RSM provided further follow-up questions to the Company regarding the updated memo.

On November 17, 2021, the Special Committee met with representatives of Ballard Spahr, its independent legal counsel, and members of management. At the meeting, management provided the Special Committee an update on certain developments and other strategic matters that may impact a potential transaction with AB. The Special Committee discussed potential options for changes to the AB transaction structure in light of management’s updates. In response to the discussion, the Special Committee requested additional information regarding such potential options from management

On November 24, 2021, the Company and Azzurro entered into a confidentiality agreement, with the intention of entering into further discussions regarding potential structuring of a transaction whereby the Company would acquire AB.

Also in November 2021, Travelzoo engaged with a financial advisor to begin evaluating other possible business combinations. In the context of the contemplated business combinations, the Company discussed with its independent financial advisor whether a possible acquisition of AB prior to a combination with a third party, with the aims of improving Travelzoo’s valuation and stock price and potentially consolidating Azzurro’s holdings of Travelzoo before entering into a stock transaction with the shareholders of any potential target, would ultimately be beneficial and in the best interests of the Company. The financial advisor ran various calculations and determined that a transaction with AB prior to any business combinations with an unrelated third party company would be beneficial as it would improve the Company’s financial statements and result in tangible equity value creation for shareholders of the Company.

On December 8, 2021, Azzurro submitted a new proposal to the Special Committee for the Company to purchase AB in exchange for 650,000 shares of the Company and $7,000,000 in cash. Upon receipt of the updated proposal and the request of the Special Committee, management prepared updated forecast numbers, the Company’s cash situation, and other open items from the previous review of a potential transaction with Azzurro.

On December 9, 2021, the Special Committee met with its independent legal and financial advisors. In light of the amount of cash requested as part of the proposal, the Special Committee was focused on ensuring that the Company had sufficient cash levels to support ongoing operations if it were to go ahead with the potential transaction and requested further
21


information regarding the same be obtained from management. The Special Committee also discussed the additional work to be completed in order to evaluate Azzurro’s latest proposal.
On December 10, 2021, Grant Thornton provided an updated draft of the technical memo. After extensive back-and-forth among the Special Committee, management and Grant Thornton, the Special Committee, along with its independent legal advisor, met first with management and then in an executive session to discuss the outstanding proposal and whether it would be feasible and in the best interests of the Company to complete before the end of the year. Management indicated that the transaction could bring immediate value for the 2021 tax year and also would allow the Company to be in a better position for other contemplated M&A activity, in terms of improved financial statements and potential equity value creation, as determined by the Company’s external financial advisor..

With the authorization of the Special Committee, the Special Committee’s independent legal advisor engaged in discussions with representatives of Azzurro regarding potential terms for a transaction. Following various discussions, the Special Committee, through its independent legal advisor, informed representatives of Azzurro that it was to prepared to accept Azzurro’s latest proposal at such time.

Accordingly, for reasons relating to timing, pricing, availability of management and the Special Committee during the holiday season and continued COVID recovery, the acquisition of AB was then paused for further consideration.

Potential Transaction with MTE (January 2022 through Present)

On January 3, 2022, MTE legally changed its name to “Metaverse Travel Experiences, Inc.” and hired a team of professionals who began building worldwide relationships with creators and providers of high quality Metaverse experiences with the goal of brokering contacts between such creators/ experience providers and businesses planning to market Metaverse experiences to consumers. On March 1, 2022, MTE entered into the Service Agreement with the Company pursuant to which MTE would scout Metaverse travel experiences and creators for the Company. In that same month, MTE sold the database to Travelzoo (after Travelzoo had successfully transitioned the email addresses and realized value of more than $1M in purchases from the database) to consolidate its business operations and focus on Metaverse experience scouting.

In April 2022, two members of the Special Committee rotated off the Board due to long tenure on the board and in support of corporate governance best practices. Also in April 2022, the Company elected two new independent directors to the Board, with one independent director continuing from before.

On May 23, 2022, Azzurro submitted a new proposal to the Company for an issuance of 3,363,000 new shares of common stock of the Company in exchange for consideration comprised of 100% of the equity interests of MTE, a cash payment of $1,000,000 and a promissory note to be paid on or before December 31, 2022.

On May 24, 2022, the board of directors of the Company re-appointed the Special Committee via a unanimous written consent, which included the two recently elected independent directors and one independent director who previously served on the Special Committee, to determine whether a potential transaction as proposed by Azzurro would be in the best interests of the Company and its stockholders, other than Azzurro and its affiliates and review, evaluate and negotiate the terms of any definitive agreements, as well as appoint independent legal, financial and other advisors, in their discretion. The new Special Committee agreed to re-appoint Ballard Spahr LLP as its independent legal advisor and Stout Risius Ross LLC as its independent financial advisor.

Management commenced updating the U.S. taxable income forecast and NOL utilization analysis for the benefit of the Special Committee. Management also coordinated with Grant Thornton on a further update of their technical memo to include more details surrounding the new transaction structure. Management also updated the presentation, previously provided to the Special Committee considering the former potential transaction, to account for the new view of management as to the updated potential transaction structure.

Management, with the approval of the Special Committee, also requested that Grant Thornton refresh its diligence report previously conducted on AB, now that the entity had become MTE. Management also refreshed its calculations regarding the shares and proposed consideration and shared with the Special Committee and its independent legal advisor.

On June 18, 2022, the Special Committee, along with its independent legal advisor, met with management of the Company to discuss the potential transaction. Following the meeting, the Special Committee requested that representatives of Ballard Spahrfurther review the tax analysis conducted by Grant Thornton.The Special Committee also authorized management of the Company to have informal discussions with various banking partners to understand potential terms for a financing transaction as an alternative to the proposed transaction.

The Special Committee also agreed that Company management in coordination with the representatives of Ballard Spahr should prepare an initial draft of a term sheet for the proposed transaction. On July 8, 2022, the Special Committee and its independent legal advisor met with members of Company management to review the proposed term sheet draft. A revised term sheet was provided to the Special Committee on July 14, 2022 in response to the Special Committee’s feedback. With the
22


approval of the Special Committee, the Special Committee’s independent legal advisor sent the draft term sheet to Azzurro on July 18, 2022.

On August 22, 2022, the Special Committee’s independent legal advisor and the Company’s General Counsel met with a representative of Azzurro to discuss the term sheet. Following that conversation, Azzurro returned comments to the term sheet for review by the Special Committee.

On August 29, 2022, the Special Committee and its independent legal advisor met with the Company’s General Counsel to discuss Azzurro’s feedback on the term sheet. Following the call, an updated draft of the term sheet was circulated for review. After additional edits, the Special Committee confirmed to its independent legal advisor that the revised draft was approved and the Special Committee’s independent legal advisor sent the revised term sheet to Azzurro on September 8, 2022.

On September 7, 2022, the scope of services being provided pursuant to the Service Agreement was amended by mutual agreement of Azzurro and the Company.

On October 18, 2022, Grant Thornton provided an updated draft of the technical memo, accounting for the new proposed transaction. Its conclusions did not materially change, however, the facts were significantly updated to account for the new Metaverse business and the fact that the proposed transaction was now structured as an issuance of shares, with a merger included as consideration, instead of just a merger transaction. Specifically, the memo was updated to review the transaction as a qualified stock purchase under section 338(d)(3) followed by a section 332 liquidation, instead of as a tax-free reorganization as was previously contemplated.

On October 31, 2022, Azzurro responded to the Special Committee’s independent legal advisor with comments to the term sheet. On November 4, 2022, the Special Committee and its independent legal advisor met with members of management to review such comments to the term sheet and the Special Committee’s feedback.The Special Committee’s independent legal advisor and Company management prepared an updated term sheet based on the Special Committee’s comments. An updated draft of the term sheet was returned to Azzurro on November 10, 2022.

Azzurro provided comments to the term sheet to the Special Committee’s independent legal advisor on November 15, 2022. In the meantime, management of the Company worked to update the U.S. taxable income forecast and NOL utilization analysis in order for Stout to provide an updated analysis. Stout also conducted a review of the VWAP of the Company’s stock price.

On November 15, 2022, Azzurro engaged Morrison Cohen LLP to act as its legal advisor in connection with the proposed transaction.

On November 17, 2022, management of the Company provided an updated U.S. taxable income forecast and NOL utilization analysis to the Special Committee and Stout.

On November 18, 2022, the Special Committee met with its independent legal advisor and management to discuss the latest term sheet. Management represented its view to the Special Committee that it would be beneficial to the Company if a transaction could be completed before the end of the year, so that any tax benefit from the NOLs could be applied against 2022, when the Company was estimated to have lower cash levels. During executive session, the Special Committee considered the feedback received from Azzurro on the term sheet and authorized the Company’s General Counsel and the Special Committee’s independent legal advisor to negotiate the remaining open items and finalize the term sheet as soon as possible. The Special Committee also provided its approval to begin preparation and negotiation of the draft Stock Purchase Agreement.

Following the meeting, the revised term sheet was delivered to Azzurro, which confirmed it had no further comments.The Company’s General Counsel, with authority granted by the Special Committee, and a representative of Azzurro, executed the nonbinding term sheet on November 18, 2022.

Thereafter, the Company’s General Counsel, along with the Special Committee’s independent legal advisor, prepared and negotiated the terms of the draft Stock Purchase Agreement with Azzurro and its counsel over the next week.

The Special Committee met on November 22, 2022 with its independent legal advisor and members of management to receive an update on the status of the Stock Purchase Agreement negotiations and provide input on certain open points.In light of feedback provided during such meeting, the Special Committee’s independent legal advisor continued negotiations with Azzurro.On November 23, 2022, the Special Committee held a meeting with its independent legal advisor and Stout, as well as, for a portion of the meeting, certain members of Company management, to present to the Special Committee Stout’s fairness analysis. The representatives of Stout reported that they were prepared to issue a fairness opinion if requested by the Special Committee.

23


From November 23 through 25, 2022, the Special Committee’s counsel, in coordination with management, continued negotiations with Azzurro in order to finalize the Stock Purchase Agreement.Also, on November 25, 2022, Stout delivered to the Special Committee its updated fairness analysis and fairness opinion, and the Special Committee approved the Stock Purchase Agreement subject to final changes agreed upon by the Special Committee.

On November 25, 2022, the Company’s General Counsel, with the unanimous approval of the special committee, and a representative of Azzurro executed the Stock Purchase Agreement.

On November 25, 2022, the Company filed a Form 8-K disclosing the execution of the Stock Purchase Agreement and then filed the preliminary proxy statement..

Description of the Stock Purchase Agreement

Consideration

On November 25, 2022, we entered into a stock purchase agreement (the “Stock Purchase Agreement”) with Azzurro, providing for the issuance of 3,410,000 shares (the “Shares”) of common stock of the Company (the “Common Stock”), in exchange for consideration comprised of (a) $10 million, payable at the election of Azzurro, in cash or as a combination of no less than $2 milion in cash and the remaining up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of MTE , such that following the consummation of the proposed issuance, Azzurro and its affiliates will own greater than 50% of the common stock of the Company. The Stock Purchase Agreement contemplates that the offer and sale of the Shares will be made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) or another available exemption from registration.

The Stock Purchase Agreement contemplates an issuance price for the Shares equal to $5.88 per share (the “Issuance Price”), which was the 15-day volume-weighted average price (“VWAP”) of the shares of common stock of the Company as of the date of execution of the Stock Purchase Agreement calculated by Stout, which results in an aggregate purchase price for the issuance of the Shares of $20,050,800.

Purchase Price Adjustment

The Stock Purchase Agreement contains a purchase price adjustment, whereby if the Nasdaq closing stock price of the Company during the period between the signing of the Stock Purchase Agreement and the closing of the transactions contemplated under the Stock Purchase Agreement (the “Closing) increases or decreases by more than 10%, with such increase sustained for 15 consecutive trading days or more, then the Issuance Price shall be increased or decreased, as applicable, to the Company’s 15-day volume-weighted average price (VWAP) of the shares of common stock of the Company as of the date of Closing.

Registration of the Shares

Following the Closing, the Company shall file a registration statement covering the resale of the Shares by Azzurro issued in exchange for the cash consideration actually paid by Azzurro at Closing and MTE.

Representations and Warranties/Indemnification

The Stock Purchase Agreement contains customary representations and warranties surrounding MTE, the business of MTE and the NOLs and a corresponding right to indemnification of the Company by Azzurro. The Stock Purchase Agreement also contains customary indemnification provisions, including for breaches of representations and warranties made by MTE and Azzurro, including tax representations relating specifically to the NOLs. In the case of a Loss (as defined in the Stock Purchase Agreement), Azzurro would be required to indemnify the Company.

Conditions That Must Be Satisfied or Waived for the Issuance to Occur

The obligations of the parties to consummate the transactions contemplated by the Stock Purchase Agreement are subject to, among other things, the approval of the stockholders of the Company, that Azzurro and its affiliates have sufficient ownership so that upon the issuance of the Shares Azzurro and its affiliates will hold more than 50.0% of the Company. Azzurro is also obligated to resolve all outstanding shareholder loans in the financial statements of MTE in a manner satisfactory to the Company. Azzurro must also have sufficient ownership prior to the Closing so that upon the issuance of the Shares, Azzurro, together with its affiliates, shall have greater than 50% ownership (in order to allow full utilization of the NOLs of MTE). The Stock Purchase Agreement also contains customary conditions to closing, such as requiring that no governmental authority shall have enacted any order which would make the transaction illegal, and that the representations,
24


warranties and covenants of MTE, Azzurro and the Company shall be true anddoes not intend to correct as of the Closing Date, and that the Investor, MTE and the Company shall have complied in all material respects with the SPA andor update any related agreements.

Termination

The Stock Purchase Agreement may be terminated at any time prior to the Closing upon the mutual written consent of the parties, by the Company if there is an increase in the Nasdaq closing stock price of the Company by 15% or more sustained for a period of 15 consecutive business days or more, and by Azzurro if there is a decrease in the Nasdaq closing stock price of the Company by 15% or more sustained for a period of 15 consecutive business days or more. The Stock Purchase Agreement contains an outside date of March 31, 2022, at which time, either party may terminate the Stock Purchase Agreement, with notice to the other party. There are no termination fees payable by either party in connection with a termination pursuant to the Stock Purchase Agreement or related agreements.

Standstill

The Stock Purchase Agreement provides that Azzurro may not, for the period of 12 months following the Closing Date and subject only to customary exceptions, sell, transfer or dispose any shares of the Company held by Azzurro if such sale, transfer or disposal would reduce the total number of shares of the Company held by Azzurro below 3,410,000 (with such minimum number of shares to be held by Azzurro not including any shares that are issued in the Issuance and pledged as collateral securing the Promissory Note).

The Stock Purchase Agreement is included as Annex A to this proxy statement. The description set forth herein is qualified in its entirety by the text of the Stock Purchase Agreement, which is incorporated by reference herein.

The Merger Agreement

The form of merger agreement (the “Merger Agreement”) attached to the Stock Purchase Agreement as Exhibit A provides that upon the closing of the Issuance, MTE will merge with and into Merger Sub Inc., a Delaware corporation (“Merger Sub"), with MTE as the surviving entity, and then, immediately following the merger of Merger Sub into MTE, and as part of the overall transaction, MTE will merge with and into Merger Sub LLC, a Delaware limited liability company (“Merger Sub LLC”) that will be disregarded as an entity separate from the Company, with Merger Sub LLC as the surviving entity.

As advised by Grant Thornton LLP (“Grant Thornton), the Company’s tax advisor, the Issuance and the Merger would be treated as a qualified stock purchase under section 338(d)(3) followed by a section 332 liquidation pursuant to the United States Internal Revenue Code of 1986, as amended (the “Code”). Additionally, upon the closing of the Issuance, Azzurro’s ownership of the Company would surpass 50%, meaning due to the overlap of Azzurro’s ownership, the acquisition would not result in an ownership change undersection 382(g) of the Code the NOLs of MTE would not be limitedforward-looking statements, whether as a result of the proposed restructuring.

A technical memorandum prepared by Grant Thornton for the Company analyzed whether the Issuance and the Merger will be treated as a qualified stock purchase under section 338(d)(3) followed by a section 332 liquidation, whether the potential transaction would not result in an ownership change under section 382(g) of the Code and whether the potential transaction is subject to section 269. Based on Grant Thornton’s analysis of the facts, Grant Thornton stated that it is more likely than not that the potential transaction will be treated as a qualified stock purchase under section 338(d)(3) followed by a section 332 liquidation, did not result in an ownership change and is not subject to Section 269, meaning it is more likely than not that the Company can fully utilize the approximately $63 million in NOLs of MTE, by applying them against the Company’s taxable income in the United States (US).

The Promissory Note

Should Azzurro be unable to pay the full $10 million in cash at the closing of the Issuance (the “Closing”), the Company is willing to accept a portion of the Purchase Price in the form of a secured promissory note (the “Promissory Note”). The Promissory Note shall be full recourse, secured by a pledge of 2 million of the Shares, representing the principal value of the Promissory Note, plus a safety margin. The Promissory Note shall contain an interest rate of 12% per annum. An amount equal to the principal amount of the Promissory Note plus interest accrued thereon until March 15, 2023 minus $3 million shall be due onnew information, future events or before March 15, 2023, and the remaining $3 million plus accrued interest for the time from March 15, 2023 until June 30, 2023 shall be due on or before June 30, 2023. The principal amounts and interest owing under the Promissory Note may be prepaid by Azzurro without penalty.otherwise.

In order to ensure the collateral under the Promissory Note remains at the right amount to provide sufficient security for Azzurro’s obligations while also not over-securing Azzurro’s obligations, there is an adjustment mechanism which
2528



allows the Company to increase and Azzurro to decrease the collateral proportionately in the case of a decrease or increase, as applicable, of the Nasdaq closing stock price of the Common Stock of 10% or more with such decrease or increase, as applicable, sustained for 15 consecutive business days or more.

Upon the occurrence of an Event of Default (as defined in the Promissory Note to include a default on payment obligations or insolvency), the Company may exercise all of the rights of a secured party under the Uniform Commercial Code, without demand, notice of any kind, etc.

The form of Promissory Note is included as Exhibit B to the Stock Purchase Agreement.

Why We Need Shareholder Approval

The Company is proposing the Issuance Proposal in order to comply with Nasdaq Listing Rule 5635(a) and 5635(d). Nasdaq Listing Rule 5635(a) requires stockholder approval prior to the issuance of securities in connection with the acquisition of the stock or assets of another company if any Substantial Shareholder (as defined by Rule 5635(e)(3)) in the consideration to be paid in the transaction and the potential issuance of common stock could result in an increase in the outstanding common shares of 5% or more. The Shares being issued, even solely in exchange for MTE and not considering the Shares issued in exchange for cash or the Promissory Note, constitute greater than 5% of the outstanding Common Stock.

Nasdaq Listing Rule 5653(d) requires stockholder approval prior to a 20% Issuance (meaning, a transaction other than a public offering, involving the issuance of common Stock by a company, which equals 20% or more of the common stock outstanding before the issuance) at a price that is less than the Minimum Price (meaning the lower of the Nasdaq Official Closing Price immediately preceding the signing of the SPA or the five-day trading average). The Shares being issued constitute approximately 27.5% of the Common Stock before the Issuance and the price of $5.88, which is based on the 15-day volume-weighted average price of the shares of common stock of the Company prior to the signing of the SPA, is less than the Minimum Price of $6.10.

Effect of the Issuance Proposal on Current Stockholders

We will issue shares of common stock that represent approximately 27.5% of our outstanding shares of common stock prior to the Issuance to Azzurro in the Issuance. When the Issuance occurs, Azzurro will have ownership of more than 50% of the Company. As a result, the percentage ownership of the Company held by each of our current stockholders will be smaller than such stockholder’s percentage ownership of the Company prior to the Issuance. Our current stockholders will, therefore, have proportionately less ownership and voting interests in the Company following the Issuance than they have now. In addition, if the value of the Shares is less than the value of the Company, then our existing stockholders will experience dilution in the value of their shares of common stock.

Interests of the Company’s Executive Officers and Directors in the Acquisition

When considering the recommendation of the Special Committee, you should be aware Azzurro is the Company’s largest stockholder and is wholly owned by The Ralph Bartel 2005 Trust, whose sole beneficiary is Ralph Bartel, the Chairman of the Board of the Company. Mr. Ralph Bartel’s brother, Mr. Holger Bartel, is the Global Chief Executive Officer of the Company and is affiliated with MTE as a member of its board of directors.

The Special Committee have taken these additional interests into considerations and ensured that a fair process was followed to avoid any conflicts of interest. The members of the Special Committee are independent, dis-interested directors, with no affiliation to Mr. Ralph Bartel, Mr. Holger Bartel, Azzurro or MTE. The Special Committee appointed independent financial and legal advisors to advise on the proposed transaction and ensure its fairness to the Company and all of its stockholders, excluding Azzurro and its affiliates.

Vote Required

The approval of the Nasdaq Stock Issuance Proposal requires the affirmative vote of a majority of the votes cast by the holders of Common Stock, voting together as a single class, as of the Record Date, present in person (which would include presence at a virtual meeting) or by proxy at the special meeting and entitled to vote thereon. Abstentions, broker non-votes and the failure to vote by proxy or in person (which would include presence at a virtual meeting) at the special meeting will have no effect on the approval of the Issuance Proposal.

Recommendation of the Special Committee of the Board of Directors

While the mechanics and purpose of the proposed transaction have evolved over time, the main business reasons for pursuing the issuance and acquisition of MTE now are, in the opinion of management of the Company and the Special Committee, (1) to strengthen Travelzoo’s balance sheet and working capital with (a) a capital injection in the form of cash and a

TABLE OF CONTENTS

26


debt note, (b) the elimination of the monthly retainer fee ($25,000 per month) and commission (25% of paid membership sales once Travelzoo META launches) payable by Travelzoo to MTE under the terms of the existing service agreement, which commission is expected to be significant, and (c) increase in available cash due to the expected elimination of tax payments by Travelzoo in the United States upon the successful completion of the proposed transaction, and (2) the building out of Travelzoo’s Metaverse business by giving Travelzoo direct control over the Metaverse scouting services and related connections. Based on the insights and experiences gained over the period since the entry into the service agreement, in particular in relation to the uncertainty of expected subscriber numbers as well as expected margins, Travelzoo’s management believes that the acquisition of MTE will likely be economically more attractive for the Company than continuing to pay the monthly fee and any future (and potentially very high) commission share under the service agreement.

In combination with the other advantages presented by the proposed transaction, a capital raise by way of the proposed issuance appears superior to alternative options. Specifically, one alternative option of obtaining a debt facility (most likely a revolving credit facility) would, as confirmed by Travelzoo’s banking partner, come with considerable restrictions in the form of covenants and pledges of security interests over Travelzoo’s most valuable assets (cash, intellectual property, subsidiaries, etc.), neither of which are present in the proposed transaction.

The other alternative option of raising equity from existing stockholders other than Azzurro or new investors presents the disadvantage that such stockholders or investors, when invited to acquire a considerable stake in a issuance, will likely request a non-negligible discount on the VWAP of the Company’s common stock. A public offering, in turn, would be more costly than an issuance because of added legal and administrative requirements. Such alternative equity issuance would also not present the added advantages of the proposed transaction relating to MTE (elimination of payment obligations under service agreement; direct control over Metaverse experience scouting; utilization of MTE’s NOLs), nor would it further management’s strategic goal to ensure long term stability and continuity in Travelzoo’s stockholder base on the basis of a robust corporate governance and compliance framework designed for a company with a controlling stockholder.

Additionally, and contrary to the outright acquisition of the database from MTE, MTE’s Metaverse scouting business is not an asset that could easily be bought by Travelzoo without acquiring MTE as a whole, since it is constituted of goodwill in the form of name recognition and contacts established on behalf of and in the name of MTE.

Management Projections

In connection with management and the Special Committee’s review of the Issuance and the Merger, management of the Company provided the Special Committee and its financial advisor, Stout, with forecasts of the expected US taxable income and utilization of the NOLs in three scenarios (scenario 1 – baseline; scenario 2 – moderate growth; and scenario 3 – slowest growth due to delayed recovery from the pandemic). The projected US taxable income and NOL utilization for each of the scenarios that management provided are as follows:

202220232024202520262027202820292030Total
Projected US Taxable Income
Scenario 1$8,588,000$15,884,700$22,387,255$24,919,705$27,674,127$ 29,450,928$31,336,224$33,336,422$35,003,243$228,580,604
Scenario 2$8,588,000$11,864,120$16,158,356$19,856,289$21,031,202$ 22,465,170$23,989,957$25,611,060$26,891,613$176,455,766
Scenario 3$7,358,000$9,172,100$12,157,215$15,080,518$15,704,871$ 16,530,209$17,390,932$18,288,421$18,837,074$130,519,340
Estimated NOL Utilization
Scenario 1$8,588,000$15,884,700$22,387,255$16,445,785$ -$ -$ -

$ -
$ -$63,305,740
Scenario 2$8,588,000$11,864,120$16,158,356$19,856,289$6,838,976$ -$ -

$ -
$ -$63,305,740
Scenario 3$7,358,000$9,172,100$12,157,215$15,080,518$19,537,907$ -

$ -

$ -
$ -$63,305,740
Cash Tax Savings (21.6%)
Scenario 1$1,855,008$3,431,095$4,835,647$3,552,290$ -$ -$ -

$ -
$ -$13,674,040
Scenario 2$1,855,008$2,562,650$3,490,205$4,288,958$1,477,219$ -$ -

$ -
$ -$13,674,040
Scenario 3$1,589,328$1,981,174$2,625,958$3,257,392$4,220,188$ -$ -

$ -
$ -$13,674,040

Opinion of Stout Risius Ross, LLC

On November 25, 2022, Stout delivered its opinion to the Special Committee that, as of November 25, 2022 and based upon the subject to the factors and assumptions set forth therein, the aggregate consideration consisting of (a) $10 million, payable, at the election of Azzurro, in cash or as a combination of no less than $2 million in cash and up to $8 million in the form of a secured promissory note; and (b) shares of common stock representing all of the outstanding equity securities of MTE, to be paid for 3,410,000 shares of Common Stock was fair, from a financial point of view, to the Company.

Stout’s opinion was directed to the Special Committee and only addressed the fairness, from a financial point of view, of the consideration to be paid by the Company pursuant the Issuance. The Opinion does not address any other
27


aspect or implication of the Issuance. The summary of Stout’s opinion in this information statement is qualified in its entirety by reference to the full text of the written opinion. The full text of the written opinion of Stout, dated November 23, 2022, which sets forth assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex B. Stout provided advisory services and its opinion for the information and assistance of the Special Committee in connection with its consideration of the Issuance. The Stout opinion is not a recommendation as to how any holder of the Company’s Common Stock should vote with respect to the Issuance or any other matter.

In arriving at its opinion, Stout reviewed, among other facts and data that they deemed relevant in reaching their conclusions:
a.The draft of the Stock Purchase Agreement, dated November 24, 2022;
b.The draft of the Secured Promissory Note agreement, received November 22, 2022, relating to the promissory note;
c.The draft of the Memorandum Regarding Azzurro Issuance, prepared by Grant Thornton, dated October 18, 2022;
d.The draft of the Tax Due Diligence Report prepared by Grant Thornton, dated June 2021;
e.The draft of the the Company Reorg Illustrative Plan, prepared by Grant Thornton, dated February 2021;
f.Certain publicly available business and financial information relating to the Company that Stout deemed to be relevant;
g.Certain information relating to the historical, current and future operations, financial condition and prospects of the Company made available to us by the Company, including:
i.certain information from the Company’s Form 10-K filings for the years ended December 31, 2017 through 2021 and Form 10-Q filing for the period ended September 30, 2022;
ii.certain information from the Company’s internally prepared income statements for its U.S. operations for the fiscal years ended December 31, 2016 through 2021, and for the year-to-date periods ended September 30, 2021 and 2022;
iii.certain information from the Company’s U.S. federal income tax returns for the fiscal years ended December 31, 2017 through 2021; and
iv.financial projections relating to the Company’s U.S. operations as prepared by Company management for the fiscal years ending December 31, 2022 through 2030.
h.The Service Agreement between MTE and the Company (Asia) Limited, a wholly owned subsidiary of the Company, dated March 1, 2022;
i.MTE’s federal income tax returns for the fiscal years ended December 31, 2018 and 2019, and internally prepared financial statements for the fiscal years ended December 31, 2011 through 2021;
j.Publicly available financial data of certain companies with publicly traded equity securities that Stout deemed relevant;
k.Discussions with the Company’s management and certain of its representatives concerning the business, industry, history, and prospects of the Company, MTE, the Issuance and related matters; and
l.A certificate from senior management of the Company containing, among other things, representations regarding the accuracy of the information, data, and other material (financial or otherwise) provided to Stout by or on behalf of the Company.

No opinion, counsel or interpretation was intended in matters that require legal, regulatory, accounting, insurance, tax or other similar professional advice. Stout was not requested to opine as to, and its opinion does not in any manner address the following: (i) the underlying business decision of the Company, its security holders, the Board, the Special Committee, or any other party to proceed with or effect the Issuance; (ii) the merits of the Issuance relative to any alternative business strategies that may exist for the Company or any other party or the effect of any other Issuances in which the Company or any other party might have engaged; (iii) the terms of any arrangements, understandings, agreements or documents related to, or the form or any other portion or aspect of, the Issuance or otherwise, except as expressly addressed in Stout’s opinion; (iv) the fairness of any portion or aspect of the Issuance to the holders of any class of securities, creditors or other constituencies of the Company, or to any other party, not specifically addressed in Stout’s opinion; (v) the solvency, creditworthiness or fair value of the Company or any other participant in the Issuance under any applicable laws relating to bankruptcy, insolvency or similar matters or (vi) how the Board, the Special Committee, the Company’s security holders or any other person should act with respect to the Issuance.

Stout’s opinion was intended to be utilized by the Special Committee as only one input to consider in its process of analyzing the Issuance. Further, Stout’s opinion was not intended to and does not constitute a recommendation to any security holder of the Company as to how such person should vote in regard to the Issuance. Moreover, Stout was not engaged to, and did not, (i) initiate any discussions with, or solicit any indications of interest from, third parties with respect to the Issuance, the assets, businesses or operations of MTE, the Company, or any other party, or any alternatives to the Issuance, or (ii) negotiate the terms of the Issuance.

Stout did not conduct a physical inspection of the Company’s or MTE’s facilities or assets. Stout assumed, with the consent of the Special Committee, that the final executed form of the Stock Purchase Agreement would not differ materially from the draft of the Stock Purchase Agreement that it examined, that the conditions to the Issuance as set forth in the draft of the Stock Purchase Agreement would be satisfied, and that the Issuance would be consummated on a timely basis in the manner contemplated by the draft of the Stock Purchase Agreement. Stout’s opinion was necessarily based on business, economic, market, and other conditions as they existed and could be evaluated by Stout at the date of its opinion. Although subsequent developments may affect Stout’s opinion, Stout does not have any obligation to update, revise, or reaffirm its opinion. Stout reserves the right, however, to withdraw, revise, or modify its opinion based upon additional information that may be provided
28


to or obtained by it after the date of its opinion that suggests, in Stout’s judgment, a material change in the assumptions upon which its opinion was based.

Stout’s opinion was furnished for the use and benefit of the Special Committee in connection with the Issuance, and is not intended to be used, and may not be used, for any other purpose, without Stout’s express, prior written consent. Stout has consented to the reproduction of its opinion in this information statement and to the inclusion of our summary of its opinion as it appears in this proxy statement.

Summary of Financial Analyses

In preparing its opinion to the Special Committee, Stout performed a variety of analyses, including those described below. The preparation of a fairness opinion is a complex process involving various quantitative and qualitative judgments and determinations with respect to the financial, comparative and other analytical methods employed and the adaptation and application of these methods to the unique facts and circumstances presented. Stout arrived at its opinion based on the results of all analyses undertaken by it and assessed as a whole. Stout did not form a conclusion as to whether any individual analysis, when considered independently of the other analyses conducted by Stout, supported or failed to support its opinion as to the fairness, from a financial point of view, of the consideration to be paid by the Company pursuant to the Stock Purchase Agreement. Further, Stout did not specifically rely or place specific weight on any individual analysis. Rather, Stout believes that its analyses must be considered in their entirety, and that selecting portions of its analyses or the factors it considered, without considering all analyses and factors together, could create a misleading or incomplete view of the processes underlying the analyses performed by Stout in connection with the preparation of its opinion. Each analytical technique has inherent strengths and weaknesses, and the nature of the available information may further affect the value of particular techniques.

In rendering its opinion, Stout assumed and relied upon the accuracy and completeness of all financial and other information that was publicly available, furnished by the Company, or otherwise reviewed by or discussed with Stout without independent verification of such information. Stout’s opinion is premised on the assumption that the assets, liabilities, financial condition, and prospects of the Company and MTE, as of the date of its opinion, have not changed materially since September 30, 2022 and December 31, 2021, respectively, the dates of the most recent financial statements made available to Stout. Stout assumed, without independent verification, the accuracy of, and relied upon, the representations and warranties contained in the draft Stock Purchase Agreement that it reviewed. Stout assumed, without independent verification, that the financial forecasts and projections provided to Stout were prepared in good faith and reflect the best currently available estimate of the future financial results of the Company, and relied upon such projections in arriving at its opinion. Stout was not engaged to assess the reasonableness or achievability of these forecasts and projections or the assumptions upon which they were based. Stout expressed no view as to those forecasts, projections, or assumptions. Stout assumed that the Issuance would be consummated on the terms described in the draft Stock Purchase Agreement, without any waiver of any material terms or conditions by the parties to the draft Stock Purchase Agreement. Stout’s opinion was necessarily based on business, economic, market, and other conditions as they existed and could be evaluated by Stout at the date of its opinion.

Stout’s opinion was provided to the Special Committee in connection with its consideration of the proposed Issuance and was only one of many factors considered by the Special Committee in evaluating the proposed Issuance. Neither Stout’s opinion nor its analyses were determinative of the Issuance consideration or of the views of the Special Committee or management with respect to the Issuance or the consideration payable therein. The type and amount of consideration payable in the Issuance were determined through negotiation between the Company/the Special Committee and Azzurro. The decision to enter into the Issuance was solely that of the Special Committee.

The implied reference range values indicated by Stout’s analyses, and the estimates upon which they are based, are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than those suggested by the analyses. In addition, any analyses relating to the value of assets, businesses or securities do not purport to be appraisals or to reflect the prices at which assets, businesses or securities may actually be sold, which may depend on a variety of factors, many of which are beyond our control. Much of the information used in, and accordingly the results of, Stout’s analyses are inherently subject to substantial uncertainty.

The following is a summary of the material analyses reviewed by Stout with the Special Committee in connection with Stout’s opinion rendered on November 25, 2022. The order of the analyses below does not represent relative importance or weight given to those analyses by Stout. In addition, the analyses summarized below include information presented in tabular format. The tables alone do not constitute a complete description of the analyses. Considering the data in the tables below without considering the full narrative description of the analyses, as well as the methodologies underlying, and the assumptions, qualifications and limitations affecting, each analysis, could create a misleading or incomplete view of Stout’s analyses.

Implied Value of the Consideration

For the purposes of its analysis, Stout calculated implied ranges of values for the consideration to be issued in the Issuance and compared these implied ranges of values of the consideration to the implied ranges of equity values to the
29


Company contributed by Azzurro in the Issuance. The consideration consists of 3,410,000 shares of common stock in the Company.

In calculating the implied range of values of the consideration (the Shares), Stout considered the historical trading activity in the Company's common stock from November 24, 2021 through November 23, 2022. During this time period, the common stock of the Company traded in a range from $4.43 per share to $10.59 per share. Stout considered the range of trading prices implied by a 20-day and a 10-day volume-weighted average price of $5.75 per share and $5.98 per share, respectively, as of November 23, 2022, as provided by Bloomberg L.P. Stout calculated a range of implied values for the Shares of $19.6 million to $20.4 million based on the 3,410,000 shares of common stock issued in the Issuance times the 20-day and 10-day volume weighted-average prices, respectively.

Discounted Cash Flow Analysis

The Company management represented that the Company was not expected to incur any incremental expenses from MTE following the Issuance. the Company management represented that the the Company Meta business was still in the startup phase, and no financial projections for the business were available. However, the Company management stated that MTE’s costs associated with the Company Meta’s business approximated the monthly payment that the Company pays to MTE under the Service Agreement. Therefore, the measurable financial impact to the Company from the Issuance was the estimated tax savings from the net operating losses (“NOLs”) from MTE and the value of the cash or the cash and promissory notes contributed to the Company.

Stout performed a discounted cash flow analysis of tax benefits of the NOLs of MTE expected to be realized by the Company based on the Company management’s financial projections. In performing its discounted cash flow analysis, Stout calculated the present values of the Company’s estimated income tax savings, based on income tax rate of 21.6%, of the Company management’s projected utilization of the NOLs for the calendar years ending December 31, 2022 through December 31, 2027 for the base case scenario, the moderate case scenario, as well as the low case scenario. These scenarios are based on Company management's long-term forecasts. The estimated income tax savings for each of these scenarios were discounted to present value based on a range of discount rates of 16.75 % to 18.75%, which were based upon the Company’s estimated required return on equity. As the Company would receive $10 million in cash or a combination of cash and promissory notes and was not expected to assume any liabilities in the Issuance, the range of present values of the estimated tax savings plus $10 million resulted in the estimated range of implied equity values to the Company in the Issuance.

The Company’s estimated required return on equity used in the analysis was based upon information from various independent sources (including the Board of Governors of the Federal Reserve, Kroll Cost of Caputal Navigator™, Bloomberg L.P. and S&P Capital IQ, Inc.) concerning market risk-free interest rates, market equity risk premiums, equity betas, small stock risk premiums, and its assumed capital structure. Further, a current market risk adjustment and a company-specific risk premium were added to the cost of equity capital in order to account for unaccounted levels of systematic risk in the market (and the low yield for risk-free securities) as well as the heightened risk of regulation in areas of geographic concentration, respectively.

Based on the assumptions above, the discounted cash flow analysis resulted in the implied equity value reference ranges for the base case, moderate, and low case scenarios, as presented below, which were compared to the implied ranges of values of the consideration in the Issuance (the Shares) of $19.6 million to $20.4 million based on the 3,410,000 shares of common stock in the Company times the 20-day and 10-day volume weighted average prices of $5.75 per share and $5.98 per share, respectively.
Implied Equity Value to the Company
Reference Range
Base case scenario$20.6 million - $20.9 million
Moderate case scenario$20.1 million - $20.4 million
Low case scenario$19.4 million - $19.8 million

After careful analysis, Stout provided an opinion to the Special Committee that the consideration to be paid by the Company in the Issuance is fair, from a financial point of view, to the Company.

Trading Range Analysis

Stout performed a trading range analysis with respect to the historical share prices of the Company’s common stock. Stout noted that the low and high closing trading prices per share of the Company’s common stock during the 52-week period ending on November 23, 2022 were $4.43 and $10.59. As of November 23, 2022, the closing price per share of was $6.29. Stout's review of the trading range was for reference only.

30


Other Matters

The Special Committee engaged Stout based on Stout’s experience and reputation. Stout is regularly engaged to render financial opinions in connection with mergers, acquisitions, divestitures, leveraged buyouts, recapitalizations, and for other purposes. The issuance of Stout’s opinion was approved by an internal committee of Stout authorized to approve opinions of this nature. the Company has agreed to pay Stout a fee of $150,000 payable upon the issuance of its opinion and paid Stout a fee of $50,000 in connection with its engagement with the Special Committee related to its consideration of a Issuance involving AB. No portion of Stout’s fee was contingent upon the successful completion of the Issuance. Further, none of Stout’s employees who worked on the engagement had any known financial interest in the assets or equity of the Company, MTE or Azzurro or the outcome of the engagement. Stout has provided financial advisory services to the Special Committee and the Company within the last two years. During 2021, Stout served as financial advisor to the Special Committee in connection with another Issuance that the Special Committee considered. Stout received a customary fee this engagement and disclosed and discussed such engagement with the Special Committee prior to serving in its capacity for the Issuance. the Company has also agreed to reimburse Stout for certain expenses and to indemnify Stout and certain related parties against certain liabilities and other losses associated with any third-party claim (including security holder actions) relating to or arising as a result of Stout’s services or engagement


THE SPECIAL COMMITTEE OF THE BOARD OF DIRECTORS OF THE COMPANY RECOMMEND A VOTE “FOR” THE ISSUANCE PROPOSAL.


31



APPROVAL OF THE ADJOURNMENT OR POSTPONEMENT OF THE SPECIAL MEETING

(Proposal No. 2)

We are asking our shareholders to consider and vote on a proposal to adjourn or postpone the special meeting to solicit additional proxies in the event that the Company fails to receive a sufficient number of votes to approve the Issuance Proposal (the “Adjournment Proposal”). The Company currently does not intend to propose adjournment or postponement at the special meeting if there are sufficient votes to approve the Issuance Proposal.

Vote Required

The Adjournment Proposal will be approved if the votes cast in favor of the Adjournment Proposal exceed the votes cast opposing the Adjournment Proposal.

Recommendation of the Special Committee of the Board of Directors

THE SPECIAL COMMITTEE OF THE BOARD OF DIRECTORS OF THE COMPANY RECOMMEND A VOTE “FOR” THE ISSUANCE PROPOSAL.

32



SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table shows the amount of our common stock beneficially owned as of November 22, 2022April 14, 2023 by (a) each director ofand nominee for election to the Board of Directors, (b) each named executive officer, (c) all executive officers and directors as a group, and (d) each person known by the Company, as of November 22, 2022,April 14, 2023, to beneficially own more than 5% of the outstanding shares of Common Stock of the Company. In general, shares "beneficially owned"“beneficially owned” include those shares a person has or shares(or shares) the power to vote, or the power to dispose of.
 
Beneficial Ownership
Beneficial Owner
Number of
Shares
Percent of
Total(4)
Beneficial Owners, Directors and Executive Officers
 
 
Ralph Bartel*(1)
8,058,720
51.80%
Holger Bartel(2)
816,000
5.25%
Christina Sindoni Ciocca(3)
62,288
0.40%
Michael Karg
Carrie Liqun Liu
Volodymyr Cherevko
Beneficial owners, directors (including nominees) and executive officers as a group (7 persons)
8,937,008
57.45%
Beneficial Ownership
Beneficial OwnerNumber of SharesPercent of Total (5)
Directors and Executive Officers 
Ralph Bartel (1)4,696,603 36.34 %
Holger Bartel (2)816,000 6.31 %
Christina Sindoni Ciocca (3)37,288 0.29 %
Michael Karg— — 
Volodymyr Cherevko— — 
Carrie Liqun Liu— — 
Wayne Lee (4)3,000 0.02 %
Directors and executive officers as a group (7 persons)5,552,891 42.96 %
* Persons Owning More Than 5% of Common Stock
(1)Ralph Bartel indirectly holds a controlling interest
*
Persons Owning More Than 5% of Common Stock
(1)
Mr. Ralph Bartel indirectly holds a controlling interest in Azzurro Capital Inc., which is the holder of 7,663,858 shares, through the Ralph Bartel 2005 Trust. Mr. Ralph Bartel directly holds 194,862 shares and 200,000 options that are exercisable on April 14, 2023 or become exercisable within 60 days of April 14, 2023.
(2)
Mr. Holger Bartel holds 300,000 options that are exercisable on April 14, 2023 or become exercisable within 60 days of April 14, 2023. Except as otherwise indicated and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all their shares of common stock. Mr. Holger Bartel holds 516,000 shares of common stock.
(3)
Ms. Christina Sindoni Ciocca holds 50,000 options that are exercisable on April 14, 2023 or become exercisable within 60 days of April 14, 2023. Except as otherwise indicated and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all their shares of common stock. Ms. Ciocca holds 12,288 shares of common stock.
(4)
For each person and group indicated in this table, percentage ownership is calculated by dividing the number of shares beneficially owned by such person or group by the 15,556,427 shares of common stock outstanding as of April 14, 2023, plus the number of shares of Common Stock that such person or group had the right to acquire within 60 days after April 14, 2023.
29

TABLE OF CONTENTS

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Under Section 16(a) of the Securities Exchange Act of 1934, the Company's directors, executive officers and the beneficial holders of more than 10% of the Company's Common Stock are required to file reports of ownership and changes in ownership with the SEC. Such directors, executive officers and beneficial holders of more than 10% of the Company's Common Stock are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file.
To the Company's knowledge, based solely on a review of the copies of such forms furnished to the Company or written representations from reporting persons, during fiscal 2022, all Section 16(a) filing requirements were satisfied on a timely basis.
30

TABLE OF CONTENTS

PRINCIPAL ACCOUNTANT FEES AND SERVICES
Independent Public Accountants
RSM US LLP (“RSM”) served as Travelzoo's independent registered public accounting firm for our 2022 and 2021 fiscal years. The Audit Committee has not yet selected our independent registered public accounting firm for our 2023 fiscal year. The Audit Committee annually reviews the performance of our independent registered public accounting firm and the fees charged for their services. This review has not yet been completed. Based upon the results of this review, the Audit Committee will determine which independent registered public accounting firm to engage to perform our annual audit. Stockholder approval of our accounting firm is not required by our Amended and Restated By-laws or otherwise required to be submitted to the stockholders. RSM representatives are expected to be present at the Annual Meeting and will be available to respond to questions at the meeting; however, they are not expected to make a formal statement.
Principal Accountant Fees and Services
The audit fees and fees for services rendered to Travelzoo charged by RSM for 2022 and 2021 are as follows:
Service
2022 Fees
2021 Fees
Audit fees(1)
$1,110,195
$881,063
Audit-related fees
Tax fees
All other fees
Total
$1,110,195
$881,063
(1)
Audit fees consisted of fees for professional services rendered for the annual audit of the Company's consolidated financial statements and review of the interim consolidated financial statements included in the quarterly reports, and audit services rendered in connection with other statutory or regulatory filings.
Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm
The Audit Committee pre-approves all audit and permissible non-audit services provided by the Company's independent registered public accounting firm. These services may include audit services, audit-related services, tax and other services. Pre-approval is generally provided for up to one year, and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The independent registered public accounting firm and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval, and the fees for the services performed to date. The Audit Committee may also pre-approve particular services on a case-by-case basis. During 2022 and 2021, all services provided by RSM were pre-approved by the Audit Committee in accordance with this policy.
31

TABLE OF CONTENTS

AUDIT COMMITTEE REPORT
The information contained in this report shall not be deemed to be “soliciting material” or “filed” with the SEC or subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), except to the extent that Travelzoo specifically incorporates it by reference into a document filed under the Securities Act of 1933, as amended (the “Securities Act”) or the Exchange Act.
The Audit Committee oversees Travelzoo's financial reporting process on behalf of the Board of Directors. Management is primarily responsible for the financial statements and reporting processes including the systems of internal controls, while the independent auditors are responsible for performing an independent audit of Travelzoo's consolidated financial statements in accordance with auditing standards of the Public Company Accounting Oversight Board (“PCAOB”), and expressing an opinion on the conformity of those financial statements with accounting principles generally accepted in the United States.
In this context, the committee has met and held discussions with management and the independent auditors regarding the Company's audited consolidated financial statements for the fiscal year ended December 31, 2022. The committee discussed with Travelzoo's independent auditors the overall scope and plan for their audit. The committee met, at least quarterly, with the independent auditors, with and without management present, and discussed the results of their examinations, their evaluations of Travelzoo's internal controls, and the overall quality of Travelzoo's financial reporting. Management represented to the committee that Travelzoo's consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States. The committee has reviewed and discussed the consolidated financial statements with management and the independent auditors, including their judgments as to the quality, not just the acceptability, of Travelzoo's accounting principles and such other matters as are required to be discussed with the committee under auditing standards of the PCAOB.
Travelzoo's independent auditors also provided to the committee the written disclosures required by applicable requirements of the PCAOB regarding the independent accountant's communications with the audit committee concerning independence, and the committee discussed with the independent auditors that firm's independence, including those matters required to be discussed by PCAOB Auditing Standard No. 16 Communications with Audit Committees.
In reliance on the reviews and discussions referred to above, the committee recommended to the Board of Directors (and the Board of Directors has approved) that the audited financial statements be included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 31, 2023. The committee has not yet selected Travelzoo's independent auditors for fiscal year 2023.
While the committee has the responsibilities and powers set forth in its charter, it is not the duty of the committee to plan or conduct audits or to determine that Travelzoo's financial statements are complete and accurate and are in accordance with generally accepted accounting principles. This is the holderresponsibility of 4,253,858 shares, through The Ralph Bartel 2005 Trust. Mr. Ralph Bartel holds 242,745 sharesmanagement and 200,000 options that are exercisable on November 22, 2022the independent auditors. Nor is it the duty of the committee to conduct investigations or become exercisable within 60 days of November 22, 2022.to ensure compliance with laws and regulations or Travelzoo's business conduct policies.
Audit Committee
Michael Karg
(Chair)
Carrie Liqun Liu
Volodymyr Cherevko
(2)Mr. Holger Bartel holds 600,000 options, 300,000 of which are exercisable on November 22, 2022 or become exercisable within 60 days of November 22, 2022. Mr. Holger Bartel holds 516,000 shares of Common Stock.
32
(3)Ms. Christina Sindoni Ciocca holds 75,000 options, 25,000 of which are exercisable on November 22, 2022 or become exercisable within 60 days of November 22, 2022. Ms. Ciocca holds 12,288 shares of Common Stock.

(4)Mr. Wayne Lee holds 3,000 shares of Common Stock.

TABLE OF CONTENTS

(5)For each person and group indicated in this table, percentage ownership is calculated by dividing the number of shares beneficially owned by such person or group by the sum of 12,399,709 shares of common stock outstanding as of November 22, 2022, plus the number of shares of Common Stock that such person or group had the right to acquire within 60 days after November 22, 2022.

DOCUMENTS INCORPORATED BY REFERENCE

The SEC allows us to “incorporate by reference” information into this document. This means that the Company can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be a part of this document, except for any information that is superseded by information that is included directly in this document or in any other subsequently filed document that also is incorporated by reference herein.

This document incorporates by reference our Annual Report on Form 10-K for the fiscal year ended December 31, 2021,2022, which was filed previously with the SEC and contains important information about the Company and its financial condition, including information contained in our 20212022 Annual Report under the captions “Financial Statements and Supplementary Data,” “Management's Discussion and Analysis of Financial Condition and Results of Operations,” “Changes in and Disagreements with Accountants on Accounting and Financial Disclosure,” and “Quantitative and Qualitative Disclosures about Market Risk.” A copy of the 20212022 Annual Report accompanies this proxy statement.

This document also incorporates by reference the Current Report on Form 8-K filed on April 6, 2023 and the Amended and Restated By-laws of the Company filed with the Current Report on Form 8-K on April 5, 2022.

33


The Company will amend this proxy statement to include or incorporate by reference any additional documents that the Company may file with the Securities and Exchange Commission under Section 13(a), 13(e), 14, or 15(d) of the Exchange Act after the date of this document to the extent required to fulfill our disclosure obligations under the Exchange Act.

The Company will provide, without charge, to each person to whom this proxy statement is delivered, upon written or oral request of such person and by first class mail or other equally prompt means within one business day of receipt of such request, a copy of any and all information that has been incorporated by reference in this proxy statement. You may obtain a copy of these documents and any amendments thereto by contacting Investor Relations, Travelzoo, 590 Madison Avenue, 35th Floor, New York, New York 10022 or by telephone at (646) 889-1857.(212) 516-1300. This proxy statement and the 20212022 Annual Report are available on the Internet at http://ir.travelzoo.com/financials-filings/annual-reports-and-proxies. These documents are also included in our SEC filings, which you can access electronically at the SEC's website at http://www.sec.gov.


ADDITIONAL INFORMATION

We are subject to the information and reporting requirements of the Securities Exchange Act of 1934, as amended, and in accordance therewith, we file periodic reports, documents and other information with the SEC relating to our business, financial statements and other matters. Such reports and other information may be inspected and are available for copying at the offices of the SEC, 100 F Street, N.E., Washington, D.C. 20549 or may be accessed at www.sec.gov. Information regarding the operation of the public reference rooms may be obtained by calling the SEC at 1-800-SEC-0330. You are encouraged to review the annual report on Form 10-K, as amended, mailed along with these proxy materials, together with any subsequent information we filed or will file with the SEC and other publicly available information. A copy of any public filing is also available, at no charge, by contacting Investor Relations, Travelzoo, 590 Madison Avenue, 35th Floor, New York, New York 10022 or by telephone at (646) 889-1857.(212) 516-1300.

INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON

No director, executive officer, nominee for election as a director or associate of any director, executive officer or nominee has any substantial interest, direct or indirect, by security holdings or otherwise, in the proposed matters to be acted upon, other than director elections and executive compensation, which is not shared by all other stockholders.
OTHER BUSINESS

The Board does not presently intend to bring any other business before the meeting and, so far as is known to the Board, no matters are to be brought before the meeting except as specified in the Notice of SpecialAnnual Meeting of Stockholders. As to any business that may properly come before the meeting, however, it is intended that proxies, in the form enclosed, will be voted in respect thereof in accordance with the judgment of the persons voting such proxies.

33

TABLE OF CONTENTS

STOCKHOLDER PROPOSALS FOR THE 2024 ANNUAL MEETING

It is contemplated that the next annual meeting of stockholders will be held on or about April 25, 2023.June 1, 2024. Stockholders may submit proposals on matters appropriate for stockholder action at annual meetings in accordance with the Company’s Amended and Restated By-laws and the rules and regulations adopted by the SEC. For a stockholder proposal to be included in the Company's proxy statement and identified in its form of proxy in connection with the Company's annual meeting of stockholders, it must be received by the Company at least 120 calendar days prior to the one-year anniversary of the date that the Company's proxy statement was released to the stockholders in connection with the previous year's annual meeting. As a result, stockholder proposals submitted for consideration at the 20232024 annual meeting must be received no later than December 26, 2022,February 2, 2024, to be included in the 20232024 proxy materials. Rule 14a-8 of the Exchange Act provides additional information regarding the content and the procedures applicable to the submission of stockholder proposals to be included in the Company's proxy materials for its next Annual Meeting.

Any such notice must be delivered or mailed to our Corporate Secretary, at Travelzoo, 590 Madison Avenue, 35th Floor, New York, NY 10022.




34



HOUSEHOLDING

We have adopted a procedure approved by the SEC called "householding."“householding.” Under this procedure, a householding notice will be sent to stockholders who have the same address and last name and do not participate in electronic delivery of proxy materials, and they will receive only one copy of our annual report and proxy statement unless one or more of these stockholders notifies us that they wish to not participate in householding and continue receiving individual copies. This procedure reduces our printing costs and postage fees. Each stockholder who participates in householding will continue to receive a separate proxy card.

The Company will promptly deliver, upon oral or written request, a separate copy of the proxy statement and annual report to any stockholder participating in householding. Stockholders who share an address with other stockholders and are eligible for householding, but currently receive multiple copies of our annual reports and proxy statements, or who have multiple accounts in their names, can authorize us to discontinue mailings of multiple annual reports and proxy statements.Requests for additional copies, or requests for a single copy to be delivered to a shared address should be directed to Investor Relations, Travelzoo, 590 Madison Avenue, 35th Floor, New York, New York 10022 or by telephone at (646) 889-1857.+1 (212) 516-1300.
34


TABLE OF CONTENTS

Appendix A
NON-QUALIFIED STOCK OPTION AGREEMENT
THIS NON-QUALIFIED STOCK OPTION AGREEMENT (this “Agreement”) is made this day of March 8, 2023, by and between Travelzoo, a Delaware corporation (the “Company”) and Christina Sindoni Ciocca (“Optionee”).
WHEREAS, Optionee has been providing services for the Company pursuant to an Employment Agreement, dated as of April 2, 2018, as amended, by and between Optionee and the Company (“Employment Agreement”); and
WHEREAS, the Company desires to grant to Optionee the option to purchase certain shares of its stock, in accordance with the terms of this Agreement, with such option intended to be a nonstatutory stock option that is not an incentive stock option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended.
NOW, THEREFORE, in consideration of the premises and of the mutual agreements hereinafter set forth, it is covenanted and agreed as follows:
1. Grant and Terms of Option. Pursuant to action of the Compensation Committee (the “Committee”) of the Board of Directors of the Company (the “Board”), the Company grants, effective March 8, 2023 (“Date of Grant”) to Optionee the option to purchase all or any part of Two Hundred Thousand (200,000) shares of the common stock of the Company, par value of $0.01 each (“Common Stock”), to vest bi-annually over a period of four (4) years as set forth in the table below, at the purchase price of $4.96 per share, which is the fair market value of the Common Stock determined as the official NASDAQ closing share price on the Date of Grant; provided, however, that the right to exercise such option shall be, and is hereby, restricted as follows:
(a) No shares may be purchased prior to June 30, 2023. Subject to the terms of this Agreement, the 200,000 stock options shall vest in eight (8) bi-annual installments as follows:
Vesting Date
Percentage of Stock


590 Madison Avenue, 35th Floor
New York, NY 10022




35


EXHIBIT INDEX
ExhibitDescription
Options Vesting
ANNEX AOn June 30, 2023
Stock Purchase Agreement entered into on November 25, 2022 by and between Travelzoo and Azzurro Capital Inc.
12.5%
ANNEX BOn December 31, 2023
Stout Risius Ross, LLC Opinion Letter delivered to Special
12.5%
On June 30, 2024
12.5%
On December 31, 2024
12.5%
On June 30, 2025
12.5%
On December 31, 2025
12.5%
On June 30, 2026
12.5%
On December 31, 2026
12.5%
On or after December 31, 2026, during the term hereof, Optionee will become entitled to purchase the entire number of shares (200,000 shares) to which this option relates.
(b) In no event may this option or any part thereof be exercised after the expiration of five (5) years from the Date of Grant, which shall be the term of the option.
(c) The purchase price of the shares subject to the option may be paid for (i) in cash, (ii) in the discretion of the Board, by tender of shares of Common Stock already owned by Optionee, or (iii) in the discretion of the Board, by such other method as the Board may determine.
(d) The option may not be exercised for a fraction of a share.
(e) The option may not be exercised if Optionee is no longer employed by the Company subject to the provisions of Section 4 of this Agreement.
(f) The option may not be exercised (i) unless and until shareholder approval is obtained and (ii) prior to the registration of the shares being offered under the Agreement, which registration shall be
A-1

TABLE OF CONTENTS

filed by the Company with the United States Securities and Exchange Commission following the Company’s next annual shareholder meeting. If shareholder approval for the option is not obtained, this grant shall be unwound and the outstanding options cancelled.
(g) The Board or the Committee shall also determine the methods by which shares of stock shall be delivered or deemed to be delivered to Optionee.
2. Anti-Dilution Provisions. In the event that, during the term of this Agreement, there is any change in the number of shares of outstanding Common Stock of the Company by reason of stock dividends, recapitalizations, mergers, consolidations, split-ups, combinations or exchanges of shares and the like, not including any issuances of shares for consideration or capital increases by the Company, the number of shares covered by this option agreement and the price thereof shall be adjusted, to the same proportionate number of shares and price as in this original agreement.
3. Non-Transferability. Neither the option hereby granted nor any rights thereunder or under this Agreement may be assigned, transferred or in any manner encumbered except by will or the laws of descent and distribution, and any attempted assignment, transfer, mortgage, pledge or encumbrance except as herein authorized, shall be void and of no effect.
The option may be exercised during Optionee's lifetime only by Optionee or his guardian or legal representative as set forth herein.
4. Termination of Employment. In the event of the termination of the Employment Agreement prior to its expiration, or to the extent the Company terminates employment of Optionee, including upon death or disability, Optionee’s (or, in the event of death, the legatee or legatees of Optionee under his last will, or his personal representatives or distributees) right to exercise the option, only to the extent it was vested and he was entitled to exercise it on the date of termination of services or employment, shall continue for 90 days after such termination but not after five (5) years from the Date of Grant. If Optionee (or, in the event of death, the legatee or legatees of Optionee under his last will, or his personal representatives or distributees) does not exercise the option within 90 days following such termination of Employment, any unexercised vested option shall be null and void.
5. Method of Exercise/Shares Issued on Exercise of Option. The option may be exercised (in whole or in part) at any time during the period specified in this Agreement, (a) by delivering to the Corporate Secretary of the Company not less than thirty (30) days prior to the date of exercise (or such shorter period as the Company shall approve) a written notice (email being acceptable) of Optionee’s intent to exercise and estimated date of exercise, and (b) by delivering to the Corporate Secretary of the Company not less than five (5) business days prior to the date of exercise (or such shorter period as the Company shall approve) (i) a written notice of exercise designating the number of shares to be purchased, signed by Optionee, and (ii) payment of the full amount of the purchase price of the shares and payment of the full amount of applicable taxes triggered by the exercise of the shares, in each case, with respect to which the option is exercised. If the written notice of exercise is delivered by mail, or by any other means of delivery, the date of delivery shall be the date the written notice is actually received by the Corporate Secretary. It is the intention of the Company that on any exercise of this option it will transfer to Optionee shares of its authorized but unissued stock or transfer Treasury shares or utilize any combination of Treasury shares and authorized but unissued shares, to satisfy its obligations to deliver shares on any exercise hereof. No rights of a shareholder shall exist with respect to the Common Stock under this option as a result of the mere grant of this option.
6. Board Administration. The Board, the Committee, or any successor or other committee authorized by the Board, subject to the express terms of this option, shall have plenary authority to interpret any provision of this option and to make any determinations necessary or advisable for the administration of this option and the exercise of the rights herein granted, and may waive or amend any provisions hereof in any manner not adversely affecting the rights granted to Optionee by the express terms hereof.
7. Option not an Incentive Stock Option. It is intended that this option shall not be treated as an incentive stock option under Section 422 of the Internal Revenue Code of 1986, as amended, or otherwise qualify for any special tax benefits to Optionee.
A-2

TABLE OF CONTENTS

8. No Contract of Employment. Nothing contained in this Agreement shall be considered or construed as creating a contract of employment for any specified period of time.
9. Restrictions on Exercise. This option may not be exercised if the issuance of Common Stock upon Optionee’s exercise or the method of payment of consideration for such Common Stock would constitute a violation of any applicable Federal or state securities law or other applicable law or regulation. As a condition to the exercise of this option, the Company may require Optionee to make any representations and warranty to the Company as may be required by any applicable law or regulation.
10. Termination of Option. Notwithstanding anything to the contrary herein, this option shall not be exercisable after the expiration of the term of five (5) years from the Date of Grant, as set forth in section 1(b) hereof.
11. Withholding upon Exercise. Prior to the issuance of shares upon the exercise of the option, the Optionee must make arrangements satisfactory to the Company to pay or provide for any applicable federal, state and local withholding obligations of the Company. The Optionee may satisfy any federal, state or local tax withholding obligation relating to the exercise of the option by any of the following means: (a) tendering a cash payment; or (b) requesting that the Company (which may or may not approve in its sole discretion) withhold shares of Common Stock from the shares of Common Stock otherwise issuable to the Optionee as a result of the exercise of the option; provided, however, that no shares of Common Stock are withheld with a value exceeding the maximum amount of tax required to be withheld by law. The Company reserves the right to withhold, in accordance with any applicable laws, from any consideration payable to Optionee any taxes required to be withheld by federal, state or local law as a result of the grant or exercise of this option. If the amount of any consideration payable to Optionee is insufficient to pay such taxes or if no consideration is payable to Optionee, upon request of the Company, Optionee shall pay to the Company in cash an amount sufficient for the Company to satisfy any Federal, state or local tax withholding requirements it may incur as a result of the grant or exercise of this option. Notwithstanding any action the Company takes with respect to any or all income tax, social insurance, payroll tax, or other tax-related withholding (“Tax-Related Items”), the ultimate liability for all Tax-Related Items is and remains the Optionee’s responsibility and the Company (a) makes no representation or undertakings regarding the treatment of any Tax-Related Items in connection with the grant, vesting, or exercise of the option or the subsequent sale of any shares acquired on exercise; and (b) does not commit to structure the option to reduce or eliminate the Optionee’s liability for Tax-Related Items.
12. Severability. Any word, phrase, clause, sentence or other provision herein which violates or is prohibited by any applicable law, court decree or public policy shall be modified as necessary to avoid the violation or prohibition and so as to make this Agreement enforceable as fully as possible under applicable law, and if such cannot be so modified, the same shall be ineffective to the extent of such violation or prohibition without invalidating or affecting the remaining provisions herein.
13. Non-Waiver of Rights. The Company’s failure to enforce at any time any of the provisions of this agreement or to require at any time performance by Optionee of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect either the validity of this agreement, or any part hereof, or the right of the Company thereafter to enforce each and every provision in accordance with the terms of this agreement.
14. Entire Agreement; Amendments. No modification, amendment or waiver of any of the provisions of this agreement shall be effective unless in writing specifically referring hereto and signed by the parties hereto. This agreement supersedes all prior agreements and understandings between Optionee and the Company to the extent that any such agreements or understandings conflict with the terms of this agreement.
15. Assignment. This agreement shall be freely assignable by the Company to and shall inure to the benefit of, and be binding upon, the Company, its successors and assigns and/or any other entity which shall succeed to the business presently being conducted by the Company.
16. Governing Law. To the extent that Federal laws do not otherwise control, all determinations made, or actions taken pursuant hereto shall be governed by the laws of the state of New York, without regard to the conflict of laws rules thereof.
[Signature Page Follows]
A-3

TABLE OF CONTENTS

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by the undersigned officer pursuant to due authorization, and Optionee has signed this Agreement to evidence his acceptance of the option herein granted and of the terms hereof, all as of the date hereof.
COMPANY:

TRAVELZOO
By:
Name: Holger Bartel
Title: Authorized Signatory
Date: March 8, 2023
OPTIONEE:
By:
Name: Christina Sindoni Ciocca
Title: General Counsel and Head of the Board of Directors of Travelzoo on November 25, 2022Global Functions
Date: March 8, 2023
A-4